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Chapter 1 • Summary 
Streptomycetes possess biosynthetic gene clusters that allow them to produce 
a multiplicity of secondary metabolites. These include pharmaceutically relevant 
compounds like prenylated phenazines as well as aminocoumarin- and glycopeptide 
antibiotics. For specific alterations in the structure of these substances an exact 
knowledge of the steps of their biosynthesis is of central importance. In this work, 
enzymes of the biosynthesis of different compounds were biochemically 
characterized. This allows structural modifications and creation of new derivatives in 
the future plus an enhancement of the production yield. 
 
The first part of this work describes the identification and characterization of the 
prenyltransferase PpzP from Streptomyces anulatus which transfers a prenyl moiety 
to a phenazine. PpzP is encoded in a cluster with genes for the biosynthesis of 
phenazine-1-carboxylic acid (PCA) and the prenyl donor dimethylallyldiphosphate 
(DMAPP). Cloning and expression of the gene and purification of PpzP resulted in a 
37 kDa soluble protein. Activity assays and mass spectrometric analyses confirmed 
the formation of a C-C bond between the C-1 atom of the isoprenoid substrate and 
the C-9 atom of the aromatic compound. In contrast to many other prenyltransferases 
the reaction of PpzP is independent of magnesium or other divalent cations. The Km 
values for the substrates were determined as 116 µM for DMAPP and 35 µM for PCA 
with a turnover number kcat of 0,435 s-1. The sequence of PpzP shows clear 
homology to the family of aromatic ABBA prenyltransferases. Therefore PpzP 
broadens the spectrum of accepted substrates of this family, previously limited to 
phenolic compounds, to phenazine derivatives.  
 
In the second part the adenylate-forming enzymes of the aminocoumarin 
biosynthetic gene cluster of rubradirin were identified and characterized. These 
enzymes catalyze the activation of L-tyrosine as a precursor of the aminocoumarin 
moiety, as well as the formation of an amide bond between an acyl moiety and this 
aminocoumarin ring. Interestingly, the cluster of rubradirin contains three genes 
coding for putative enzymes that may catalyze this reaction. Therefore, all three 
genes were cloned and expressed and the proteins purified for biochemical studies. 
The 55 kDa Orf4 was shown to be an active amide synthetase in vitro. However, the 
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56 kDa RubF6 was inactive despite its 88 % sequence identity to Orf4, but site 
directed mutagenesis of the ATP-binding loop converted it into an active enzyme. 
The third 138 kDa protein, RubC1, was shown to be a unique bifunctional enzyme. It 
is comprised of an amide synthetase domain as well as a domain for L-tyrosine 
adenylation with subsequent binding on a peptidyl carrier domain. This natural hybrid 
enzyme is singular among known proteins and presents a particularly effective 
machinery for aminocoumarin antibiotic biosynthesis. 
 
The third part is concerned with MbtH-like proteins. Their effect on enzymes 
that catalyze the adenylation of amino acids was characterized biochemically. The 
MbtH-like proteins, comprised of approximately 70 amino acids, are encoded in gene 
clusters of non-ribosomal peptide synthetases. Their function in the biosynthesis was 
unknown at the beginning of this study but has recently been elucidated, with this 
study contributing to it. Investigation of the role of MbtH-like proteins in the 
biosynthesis of the aminocoumarin antibiotics novobiocin, clorobiocin and 
simocyclinone D8 as well as the glycopeptide antibiotic vancomycin proved that they 
influence the activity of tyrosine-adenylating enzymes. It could be shown that the 
tyrosine-activating enzymes CloH, SimH and Pcza361.18, involved in the 
biosynthesis of clorobiocin, simocyclinone D8 and vancomycin, respectively, require 
the presence of MbtH-like proteins in a molar ratio of 1:1. They form a heterotetramer 
consisting of two adenylating enzymes and two MbtH-like proteins. In contrast, NovH 
from novobiocin biosynthesis showed activity even in the absence of MbtH-like 
proteins, but could be stimulated by them. NovH and CloH share 83 % identity in their 
amino acid sequence, yet show a striking difference in their requirement for MbtH-like 
proteins. To further this phenomenon, 3D structure models were created and 
compared. This showed that one amino acid differs in the otherwise complete 
conserved active center. A site-directed mutagenesis of this amino acid in CloH 
(L383M) indeed resulted in an MbtH-independent mutant. All investigated tyrosine-
adenylating enzymes exhibited remarkable promiscuity for MbtH-like proteins from 
different pathways and organisms. Additionally, the MbtH-like protein YbdZ from E. 
coli was found to co-purify with the heterologously expressed tyrosine-adenylating 
enzymes, leading to incorrect biochemical results. Therefore, a knock-out strain was 
created in which the corresponding gene was deleted. This was of central importance 
for a reliable biochemical characterization of the tyrosine-adenylating enzymes. 
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Chapter 2 • Zusammenfassung 
Streptomyceten besitzen Biosynthese-Gencluster, die sie befähigen eine Vielzahl 
von sekundären Metaboliten zu bilden. Darunter befinden sich auch pharmazeutisch 
relevante Verbindungen wie prenylierte Phenazine sowie Aminocoumarin- und 
Glycopeptid-Antibiotika. Für die gezielte Veränderung dieser Substanzen ist ein 
genaues Verständnis der Abläufe ihrer Biosynthese unerlässlich. In dieser Arbeit 
wurden Enzyme der Biosynthese von verschiedenen Verbindungen biochemisch 
charakterisiert. Dies erlaubt in Zukunft Modifikationen der chemischen Strukturen und 
die Herstellung neuer Derivate sowie eine Verbesserung der Produktausbeute. 
 
Im ersten Teil der Arbeit wurde die Prenyltransferase PpzP aus Streptomyces 
anulatus identifiziert und charakterisiert, welche eine Prenyleinheit auf ein Phenazin 
überträgt. ppzP liegt in einem Cluster mit den Genen für die Biosynthese von 
Phenazin-1-Carbonsäure (PCA) und dem Prenyldonor Dimethylallyldiphosphat 
(DMAPP). Klonierung und Expression des Gens und Reinigung von PpzP führte zu 
einem 37 kDa großen, löslichen Protein. Aktivitätstest und massenspektrometrische 
Untersuchungen bestätigten die Bildung einer C-C Bindung zwischen dem C1-Atom 
des isoprenoiden Substrats und dem C9-Atom des Aromaten. Dabei ist die Reaktion 
von PpzP im Gegensatz zu vielen anderen Prenyltransferasen unabhängig von 
Magnesium oder anderen zweiwertigen Kationen. Die Km-Werte für die Substrate 
wurden mit 116 µM für DMAPP und 35 µM für PCA bestimmt mit einer Wechselzahl 
kcat von 0,435 s-1. Die Sequenz von PpzP zeigt deutliche Homologie zu der Familie 
von aromatischen ABBA-Prenyltransferasen. Dadurch erweitert PpzP den Bereich 
der von dieser Familie akzeptierten Substrate, der bisher nur phenolische 
Verbindungen enthielt, um Phenazin-Derivate. 
 
Der zweite Teil beschreibt die Identifizierung und Charakterisierung der adenylat-
bildenden Enzyme aus dem Gencluster des Aminocoumarin-Antibiotikums 
Rubradirin. Diese Enzyme werden für die Aktivierung von L-Tyrosin als Vorstufe des 
Aminocoumarin-Rings benötigt, weiterhin für die Bildung einer Amidbindung 
zwischen einer Acyl-Einheit und jenem Aminocoumarin Ring. Überraschenderweise 
enthält das Biosynthese-Gencluster von Rubradirin drei putative Gene, die diese 
Reaktion katalysieren könnten. Daher wurden alle drei Gene kloniert und exprimiert 
und die Proteine gereinigt und biochemisch charakterisiert. Für das 55 kDa große 
Protein Orf4 konnte eine in vitro Amidsynthetaseaktivität nachgewiesen werden. Das 
56 kDa große Protein RubF6 hingegen war trotz einer 88 %igen Sequenzidentität zu 
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Orf4 inaktiv, konnte jedoch durch zielgerichtete Mutagenese der ATP-bindenden 
Schleife in ein aktives Enzym umgewandelt werden. Das dritte Protein, RubC1 mit 
138 kDa, wurde als bifunktionales Enzym identifiziert. Es umfasst sowohl eine 
Amidsynthetase-Domäne als auch eine Domäne für die Adenylierung von L-Tyrosin 
und anschließende Bindung an eine Peptidyl-Carrier-Domäne. Solch eine hybride 
Zusammensetzung dieser Domänen ist bislang einzigartig und zeigt einen sehr 
effizienten Mechanismus für die Biosynthese von Aminocoumarin Antibiotika auf. 
 
Der dritte Teil befasst sich mit MbtH-ähnlichen Proteinen. Dabei wurde ihre Wirkung 
auf Enzyme, welche die Adenylierung von Aminosäuren katalysieren, biochemisch 
untersucht. Die rund 70 Aminosäuren umfassenden MbtH-ähnlichen Proteine sind in 
Biosynthese-Genclustern codiert, die Peptide über nicht-ribosomale 
Peptidsynthetasen bilden. Für die Untersuchung der Funktion von MbtH-ähnlichen 
Proteinen, die zu Beginn dieser Studie unbekannt war, wurden verschiedene 
Antibiotika-Biosynthese-Gencluster hinzugezogen. Im speziellen waren dies die 
Cluster der Aminocoumarin-Antibiotika Novobiocin, Clorobiocin und Simocyclinon D8 
sowie des Glycopeptid-Antibiotikums Vancomycin. Dabei zeigte sich, dass MbtH-
ähnliche Proteine die Aktivität der Tyrosin-adenylierenden Enzyme beeinflussen. Die 
Tyrosin-aktivierenden Enzyme der Clorobiocin, Simocyclinon D8 und Vancomycin 
Biosynthese, CLoH, SimH und Pcza361.18 benötigen ein MbtH-ähnliches Protein in 
einem molaren Verhältnis von 1:1 für optimale Aktivität. Dabei formen die Proteine 
ein Heterotetramer aus je zwei adenylierenden Enzymen und je zwei MbtH-ähnlichen 
Proteinen. Im Gegensatz dazu benötigt NovH aus der Novobiocin-Biosynthese kein 
MbtH-ähnliches Protein, wird jedoch durch dessen Zugabe in seiner Aktivität 
gesteigert. Um den Unterschied in der MbtH-Abhängigkeit zwischen den zu 83 % 
identischen Proteinen NovH und CloH zu untersuchen, wurden 3D-Strukturmodelle 
erstellt und verglichen. Dabei war nur eine Aminosäure im ansonsten identischen 
aktiven Zentrum verschieden. Eine zielgerichtete Mutagenese dieser Aminosäure in 
CloH (L383M) führte zu einer MbtH-Unabhängigkeit dieser Mutante. Die 
Abhängigkeit der Tyrosin-aktivierenden Enzyme beschränkte sich nicht auf ein 
spezifisches MbtH Protein, sondern ließ sich auch mit Homologen aus andern 
Clustern stimulieren. Insbesondere das MbtH-ähnliche Protein YbdZ aus E. coli 
führte durch die Co-Reinigung der heterolog exprimierten Tyrosin-adenylierenden 
Enzyme zu einer Verfälschung der Aktivitätsmessungen. Daher wurde ein knock-out 
Stamm erstellt, in dem das entsprechende Gen deletiert wurde. Dies war von 
zentraler Wichtigkeit für eine zuverlässige Charakterisierung der Tyrosin-
aktivierenden Enzyme. 
Chapter 3 Introduction
 
Page 5  
 
Chapter 3 • Introduction 
1. Streptomycetes and their secondary metabolites 
Streptomycetes are Gram-positive, filamentous bacteria and belong to the order 
Actinomycetales. Their DNA has a high G+C content (> 70 %) and their genome 
spans over 8 – 10 Mb (Bentley et al. 2004; Bibb et al. 1984; Ikeda and Nakagawa 
2003). They are found predominantly in soil and represent an important part of the 
microflora, noted for their distinct odor which results from production of a volatile 
metabolite, geosmin. They form a mycelium which consists of a network of branching 
filaments of cells, similar in appearance to the mycelium of some fungi. Under certain 
conditions, caused by not completely understood stimuli emanating from the 
environment or from cellular metabolism, the mycelium differentiate from aerial 
filaments into spores (Chater 1998; Chater 2001). 
In addition to their particularly large genome they contain giant linear plasmids 
(Kinashi 2011). This plasmids and the linear genome contain genes for the 
biosynthesis of secondary metabolites organized in clusters, i.e., cohered parts on 
the genome. They possess all genes required for biosynthesis, regulation and 
resistance, e.g. for a specific antibiotic compound. Since Waksman discovered 
streptomycin as the first therapeutically useful Streptomyces antibiotic in the year 
1943, it has been found that Streptomycetes synthesize an amazing variety of 
chemically distinct inhibitors of many different cellular processes (Chater et al. 2010). 
So far, more than 7000 different secondary metabolites have been discovered in 
Streptomyces isolates (Bérdy 2005) and more than 3000 bioactive compounds could 
be isolated, e.g. important antibiotics like tetracyclines, vancomycin and 
erythromycin. A mathematical model in 2001 estimated that this genus is capable of 
producing a total number of antimicrobials in the order of a 100,000 (Watve et al. 
2001). Furthermore, substances effective as cytostatics, antifungal agents, 
virostatics, immunosuppressants and herbicides have been found (von Döhren and 
Gräfe 2008). This makes the Streptomycetes an extraordinary interesting class from 
the pharmaceutical point of view. 
The development of molecular microbiology and recombinant DNA technology 
led to an increased knowledge about DNA sequences and a detailed comprehension 
of the genetic and biochemical principals of secondary metabolites. The increasing 
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sequencing of genomes as well as the isolation and characterization of gene clusters 
involved in the biosynthesis of secondary metabolites and the elucidation of the 
biochemical steps improved the understanding of the biosynthetic machineries and 
regulatory networks of a targeted molecule and its related metabolic fluxes. The 
development of tools and methodologies to efficiently carry out genetic manipulations 
in the producers has strengthened the effectiveness of combinatorial biosynthesis 
and metabolic engineering (Chen et al. 2010). 
 
2. Aminocoumarin antibiotics 
Aminocoumarin antibiotics are produced by different Streptomyces strains. 
There are three structural related aminocoumarin antibiotics, novobiocin produced by 
S. niveus (syn. S. spheroides NCIMB 11891) (Hoeksema et al. 1955), clorobiocin 
from S. roseochromogenes var. oscitans DC 12.976 (Mancy et al. 1974) and 
coumermycin A1 from S. rishiriensis (Berger and Batcho 1978). Two more 
aminocoumarin antibiotics have been discovered, namely simocyclinone D8 from S. 
antibioticus Tü 6040 (Holzenkämpfer et al. 2002a; Schimana et al. 2000) and 
rubradirin produced by S. achromogenes var. rubradiris NRRL3061 (Bhuyan et al. 
1965; Sohng et al. 1997). The structural moiety of the aminocoumarin antibiotics that 
is giving them their name is a 3-amino-4,7-dihydroxycoumarin moiety, which is linked 
via an amide bond to an acyl moiety. While all aminocoumarin share this feature, 
they differ in the acyl moiety. In novobiocin, clorobiocin and coumermycin A1, the 
aminocoumarin ring is linked to the deoxysugar noviose by a glycosidic bond (Heide 
2009a).  
The biological effects of clorobiocin, novobiocin and simocyclinone D8 have 
been studied extensively (Edwards et al. 2009; Maxwell and Lawson 2003). The 
aminocoumarins inhibit the DNA gyrase by binding to this target with extremely high 
affinity, which is two orders of magnitude lower than modern fluoroquinolones 
(Maxwell and Lawson 2003). Since prokaryotic gyrases and topoisomerases IV from 
the type II topoisomerases are different from eukaryotic topoisomerases (Champoux 
2001), they are a promising anti-infective drug target. Crystallographic studies of 
clorobiocin in complex with gyrase from E. coli or S. aureus showed that only the 
aminocoumarin ring and noviose are essential for the interactions with gyrase (Lewis 
et al. 1996; Tsai et al. 1997). 
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Figure 1 Chemical structures of the aminocoumarin antibiotics. 
 
In contrast, simocyclinone D8 inhibits DNA gyrase by a completely new mode of 
action that has been shown in recent biochemical and X-ray crystallographic studies. 
Simocyclinone D8 interacts with two separate pockets of the enzyme and thereby 
prevents its binding to DNA (Edwards et al. 2009; Flatman et al. 2005; Oppegard et 
al. 2009). 
A completely different mode of action can be observed for rubradirin. It exhibits 
activity against many Gram-positive bacteria, including Staphylococcus aureus 
strains with multiple antibiotic resistance (Bhuyan et al. 1965). Whereas rubradirin 
inhibits translation at the bacterial ribosomes (Reusser 1973), the rubradirin aglycone 
has been shown to inhibit bacterial RNA polymerase by a different mechanism from 
those of ansamycins such as rifamycins, streptovaricins, and tolypomycins (Wherli 
1977). Further biological effects of the rubradirin aglycone have also been described 
(Reusser 1979; Reusser 1988). 
Of all aminocoumarin antibiotics, only novobiocin has been licensed in the 
United States in 1964 (Albamycin®, Pharmacia & Upjohn, now Pfizer) for the 
treatment of human infections with multi resistant bacteria such as Staphylococcus 
aureus and Staphylococcus epidermidis. However, clinical use of Albamycin® 
remained restricted due to its toxicity in eukaryotes, poor solubility in water, quick 
development of drug resistance and low activity against Gram-negative bacteria 
(resulting from poor permeability). Since it was no longer produced and sold, Pfizer 
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requested a withdrawal that was approved by the United States Food and Drug 
Administration (FDA) in 2009. 
In addition to their antimicrobial activity, novobiocin and its derivatives showed 
an synergistic effect with antitumor drugs to reduce drug resistance (Duan and You 
2009; Rappa et al. 2000; Shiozawa et al. 2004; Su et al. 2007). Furthermore, 
interactions between novobiocin and its derivatives with the eukaryotic heat shock 
protein 90 (Hsp90) have been observed (Marcu et al. 2000). Hsp90 is a ubiquitous 
heat shock protein in eukaryotes, plays a key role in protein folding, signaling 
systems (e.g. Raf-1) and tumor repression, and is an emerging target for rational 
chemotherapy of many cancers (Whitesell and Lindquist 2005). Novobiocin was 
found to bind to Hsp90 in vitro and led to markedly reduced cellular levels of 
oncogenic kinases in vitro and in vivo (mice) (Burlison et al. 2006; Marcu et al. 2000). 
The biosynthetic gene clusters of all known aminocoumarin antibiotics have 
been identified, cloned and sequenced. For the clusters of novobiocin (Steffensky et 
al. 2000a), clorobiocin (Pojer et al. 2002) and coumermycin A1 (Wang et al. 2000) the 
function of nearly all genes has been elucidated and the biosynthesis of these 
compounds are among the best-known pathways in secondary metabolite 
biosynthesis in Streptomycetes. The clusters of novobiocin, clorobiocin and 
coumermycin A1 span over 23.4, 35.6 and 38.2 kb and code for 20, 29 and 31 
putative proteins, respectively (Li and Heide 2006). The biosynthetic gene clusters of 
simocyclinone D8 and rubradirin have also been identified and sequenced (Galm et 
al. 2002; Kim et al. 2008; Recktenwald et al. 2002), but only few experimental data 
are available concerning their biosynthesis. The clusters of simocyclinone and 
rubradirin are larger, spanning over approximately 65 and 105 kb, respectively, and 
their precise borders have not yet been defined (Heide 2009a). 
Comparison of the novobiocin gene cluster to the gene clusters of clorobiocin 
and coumermycin A1 revealed a strikingly stringent accordance between the structure 
of the antibiotics and the organization of the biosynthetic genes. 
The biosynthesis starts with the 3-amino-4,7-dihydroxy coumarin moiety, which 
is present in all aminocoumarins. Therefore, all clusters contain a group of three to 
four genes for its biosynthesis, i.e. novHIJK, cloHIJK, couHIJK, rubC1C2C3 and 
simHIJK. NovH, CloH, CouH, SimH and RubC1 are non-ribosomal peptide 
synthetases (see 3.4.2) and comprise an adenylation domain (A) and a 
phosphopantetheinyl carrier domain (PCP) (Chen and Walsh 2001). After activation 
Chapter 3 Introduction
 
Page 9  
 
and binding of L-tyrosine to the PCP domain, L-tyrosine is β-hydroxylated by the 
P450 enzyme NovI (or CloI, CouI, SimI and RubC2) (Chen and Walsh 2001). This is 
very similar to the biosynthesis of β-hydroxytyrosine in glycopeptides as vancomycin 
(see 3.5). The β-OH-tyrosine is further reduced by NovJK (or CloJK, CouJK, SimJK 
and RubC3) to β-keto-tyrosine (Pacholec et al. 2005b). These enzymes show 
similarities to 3-oxoacyl-[acylcarrierprotein]-reductases from polyketide and fatty acid 
biosynthesis. The final step of the biosynthesis of the aminocoumarin moiety has not 
yet been elucidated. Experiments showed that a hydroxyl group is introduced into 
position 2 of the aromatic ring during the biosynthesis and speculation arose that this 
occurs in the β-keto-tyrosyl-S-NovH moiety, followed by a nucleophilic attack of this 
hydroxyl group on the thioester. This would lead to cleavage of the thioester bond 
and cyclization of the aminocoumarin ring. The clorobiocin, coumermycin A1 and 
simocyclinone gene clusters contain a small set of open readings frame, cloY, couY 
and simY, which show sequence similarity to the gene mbtH from the biosynthetic 
gene cluster of the siderophore mycobactin from Mycobacterium tuberculosis (see 
3.6). Their gene products interact with CloH, CouH and SimH in the adenylation 
reaction of L-tyrosine and are center of the investigations in chapter 7. 
The 3-dimethylallyl-4-hydroxybenzoyl moiety of novobiocin and clorobiocin is 
formed from 4-hydroxyphenylpyruvate by the gene products of novFQR and cloFQR 
(Heide 2009a). The prephenate dehydrogenases NovF and CloF provide 4-
hydroxyphenylpyruvate that is prenylated by an aromatic prenyltransferase (see 3.3) 
CloQ (Pojer et al. 2003b) or NovQ (Ozaki et al. 2009). The bifunctional non-heme 
iron(II)-dependent oxygenase CloR and NovR yield the final product via two 
consecutive oxidative decarboxylation steps (Pojer et al. 2003a). The acyl moieties in 
coumermycin, rubradirin and simocyclinone are structurally completely different from 
the moiety of novobiocin and clorobiocin (Fig. 1). Their biosynthesis has not yet been 
experimentally examined. 
The aminocoumarin moiety is linked to the respective acyl moiety by an amide 
synthetase, e.g. NovL, CloL, CouL, SimL, Orf4 or RubC1, which are described in 
3.4.1. After linkage, the aminocoumarin moieties of novobiocin and coumermycin A1 
are methylated by the methyl transferases NovO and CouO respectively (Li et al. 
2002). Clorobiocin and simocyclinone D8 contain a chlorine atom and 
correspondingly the gene cluster of clorobiocin contains a gene clo-hal encoding a 
FAD-dependent halogenase (Eustáquio et al. 2003a). The simocyclinone cluster also 
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contains a similar halogenase termed simD4 (Trefzer et al. 2002) but there is no 
experimental data available. Biochemical investigations proved that the modification 
of the aminocoumarin ring occurs after formation of the amide bond (Anderle et al. 
2007; Pacholec et al. 2005c). 
The deoxysugar moiety 5-C-methyl-L-rhamnose is synthesized by the products 
of a group of five genes (novSTUVW) and these genes have orthologues in the other 
antibiotic gene clusters. The glycosyl transferases NovM, CloM and CouM catalyze 
the transfer of the dTDP-activated deoxysugar to the 7-hydroxy group of the 
aminocoumarin moiety (Freel Meyers et al. 2003). After linkage to the aminocoumarin 
ring, the deoxysugar is methylated by the SAM-dependent methyltransferases NovP, 
CloP or CouPv (Freel Meyers et al. 2004). 
As final step in the biosynthesis the deoxysugar is acylated on its 3-hydroxy 
group. In novobiocin NovN transfers a carbamoyl moiety (Freel Meyers et al. 2004), 
while in clorobiocin and coumermycin A1 the corresponding acyl moiety is a pyrrol-2-
carboxylic acid formed by the gene products cloN1-7 and couN1-7. 
For the regulation of the biosynthesis, all three clusters contain also two positive 
regulators, novE (Eustáquio et al. 2003b) and novG (Dangel et al. 2008; Eustáquio et 
al. 2005) and their orthologs. The gene gyrBR encodes an aminocoumarin-resistant 
gyrase B subunit. Because clorobiocin and coumermycin A1 are potent inhibitors of 
topoisomerase IV, their gene clusters contain an additional resistance gene parY R 
(Schmutz et al. 2003) that encodes an aminocoumarin resistant topoisomerase IV 
subunit. 
The intensive knowledge of aminocoumarin biosynthesis allows direct 
optimization of production yield as well as modification of specific biosynthetic steps 
and the resulting antibiotic. Therefore, it is possible to create a large diversity of new 
aminocoumarin derivatives using metabolic engineering, combinatorial biosynthesis 
and mutasynthesis to overcome known restriction like reduced uptake or adverse 
effects (Alt et al. 2011; Heide 2009b). 
 
3. Prenyltransferases 
Prenyltransferases catalyze the transfer of isoprenoid moieties to acceptor 
molecules. The group of allylic prenyltransferases catalyzes a reaction which 
proceeds through formation of a carbocation during the cleavage of pyrophosphate 
group from C-1 of the allylic substrate DMAPP or GPP followed by a stereoselective 
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electrophilic alkylation of the carbon–carbon double bond in IPP by the allylic 
substrate. They are further divided into two classes, cis (or Z) and trans (or E), 
depending upon the stereochemistry of the resulting products. An archetypical allylic 
prenyltransferase is the well-examined FPP synthase (Poulter 2006) from primary 
metabolism that is involved in the synthesis of membrane sterols in all living 
organisms. Like all trans-prenyldiphosphate synthetases, FPP synthase contains two 
conserved (N/D)DxxD motifs for binding of the allylic and homoallylic substrate. The 
substrate binds in form of a Mg2+ complex, and the aspartate-rich motifs provides 
chelation of the Mg2+ ion. The three dimensional structure of trans-prenyltransferases 
consists exclusively of α-helices (Liang et al. 2002). 
Aromatic prenyltransferases can catalyze the transfer of prenyl moieties like 
DMAPP, GPP or FPP to aromatic acceptor molecules. They catalyze an electrophilic 
substitution at the aromatic acceptor molecule forming a C-C bond between C-1 (for 
regular prenylation) or C-3 (for reverse prenylation) of the allylic isoprenoid moieties. 
Some aromatic prenyltransferases have been investigated, mostly enzymes of 
primary metabolism e.g. UbiA from ubichinone biosynthesis (Melzer and Heide 
1994), MenA and UBIAD1 from menachinone biosynthesis (Nakagawa et al. 2010; 
Suvarna et al. 1998), Slr1736 from tocopherol biosynthesis (Schledz et al. 2001) and 
Pds2 from plastochinone biosynthesis (Collakova and DellaPenna 2001). Similar 
enzymes are involved in the secondary metabolism of plants in formation of 
prenylated flavonoids and isoflavanoids as well as shikonin (Yazaki et al. 2009). Very 
recently several membrane bound prenyltransferases for secondary metabolites have 
been reported in microorganisms, e.g. farnesyltransferase AuaA from Stigmatella 
aurantiaca that catalyzes the prenylation of 2-methyl-4-hydroxyquinoline in the 
biosynthesis of aurachins (Stec et al. 2011). These prenyltransferases are integral 
membrane proteins and their structure has not been determined to date. However, 
two models of this group have been published (Bräuer et al. 2008; Ohara et al. 
2009). Like FPP synthetases, members of this group exhibit (N/D)DxxD motifs for 
substrate binding and are Mg2+ dependent. 
A new group of soluble aromatic prenyltransferases has been identified in the 
last years. The first bacterial enzyme was CloQ from the biosynthesis of clorobiocin 
(Pojer et al. 2003b). CloQ and NovQ (Ozaki et al. 2009) catalyze the prenylation of 4-
hydroxyphenylpyruvate with DMAPP as prenyl donor. In 2005 the structure of NphB 
from the biosynthetic gene cluster of the meroterpenoid (prenylated polyketide) 
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naphterpin was elucidated (Kuzuyama et al. 2005). It showed a new type of β/α 
barrel fold with antiparallel strands. The α-β-β-α architecture of this fold led to the 
name ABBA prenyltransferases for this group of enzymes (Tello et al. 2008). Many 
more genes with sequence similarity have been identified from bacteria and fungi and 
characterized biochemically. These enzymes do not show a (N/D)DxxD motif and 
are, with exception of NphB, Mg2+ independent. They include PpzP from 
Streptomyces anulatus that is responsible for the prenylation reaction in the 
biosynthesis of endophenazine A and is a focus of the investigation of the publication 
in chapter 5. 
Another group of aromatic prenyltransferases has been identified and 
characterized mostly from fungi but also from bacteria (Edwards and Gerwick 2004; 
Schultz et al. 2010; Steffan et al. 2009). They mostly catalyze the prenylation of 
indole moieties, are soluble proteins, do not contain a (N/D)DxxD motif and are Mg2+ 
independent. This group has similar properties but share no sequence similarity with 
enzymes of the CloQ/NphB group. Surprisingly, the three dimensional structure of 
FgaPT2 from Aspergillus fumigatus revealed the same α-β-β-α architecture (Metzger 
et al. 2009). 
The prenylation of aromatic moieties has led to a huge variety of secondary 
metabolites in nature. Aromatic prenyltransferases are important enzymes for 
exploring novel isoprenoid substitutions in aromatic compounds because the 
presence of the isoprenoid chain can lead to impressive changes in biological 
activity. This is mostly attributed to an increased affinity for biological membranes and 
to an improved interaction with proteins (Botta et al. 2005b). The structures of ABBA 
prenyltransferases show a central cavity for the substrates that allow promiscuous 
prenylation of different aromatic substrates. Site directed mutagenesis guided by 
mechanistic insights from structural biology may broaden their substrate range. 
Therefore, prenyltransferases represent attractive tools in the chemoenzymatic 
generation of bioactive compounds (Botta et al. 2005a; Koehl 2005; Macone et al. 
2009).  
 
4. Adenylate-forming enzymes 
Adenylate-forming enzymes catalyze the activation of the otherwise unreactive 
carboxylic acid by the transfer of ATP. They are involved in a variety of metabolic 
pathways such as ribosomal and non-ribosomal peptide synthesis, fatty acid 
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oxidation or enzyme regulation (Schmelz and Naismith 2009). Based on sequence 
similarity, a superfamily was formed that was divided into four groups (Fulda et al. 
1994). This classification has been extended recently to include the structurally 
distinct aminoacyl-tRNA synthetases and enzymes involved in NRPS-independent 
siderophores (NIS). Class I now comprises the three subclasses of NRPS 
adenylation domains (Ia), acyl- or aryl CoA-synthetases (Ib) and oxidoreductases 
(Ic). Class II contains all aminoacyl-tRNA synthetases while class III includes the NIS 
(Schmelz and Naismith 2009). All three subclasses activate their substrate via 
adenylation but only subclass Ib forms a covalent thioester bond. 
The condensation between the weakly nucleophilic carboxylic acid and weakly 
electrophilic phosphate forms a transition state with a negatively pentavalent 
phosphorus atom and results in an adenylated carboxylate. As this intermediate is 
very reactive, the enzyme catalyzes a second step, i.e. the reaction with a 
nucleophile (either amine, alcohol or thiol). This leads to the desired product while 
AMP is released (Fig. 2). Two families of adenylate-forming enzymes that are 
important for secondary metabolite production are introduced here in detail. 
 
Figure 2 Adenylation reaction catalyzed by adenylate-forming enzymes. First step: adenylation 
of carboxylate. Second step: transfer of the nucleophile to an alcohol, amid or sulfhydryl 
moiety. Figure modified from (Schmelz and Naismith 2009) 
 
4.1. Amide synthetases 
Amide synthetases are similar to class I of adenylate-forming enzymes 
(Schmelz and Naismith 2009; Turgay et al. 1992), i.e. subclass Ia with A-domains 
and subclasses Ib and Ic with acyl- or aryl-CoA-synthetases and oxidoreductases. 
Amide synthetases share some sequence motifs typical for adenylate-forming 
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enzymes like 4-coumarate-CoA-ligase (Stuible et al. 2000) and A-domains from 
NRPS enzymes (Marahiel et al. 1997). But in contrast to non-ribosomal peptide 
synthetases, amide synthetases do not show a 5’-phosphopantetheinyl attachment 
site.  
Amide synthetases catalyze one of the first steps in the biosynthesis of 
aminocoumarin antibiotics, the formation of the amide bond between aminocoumarin 
ring and acyl component via an amide bond. The enzymes in their respective 
biosynthetic gene clusters have been identified as NovL (Steffensky et al. 2000b), 
CloL (Galm et al. 2004a), CouL (Schmutz et al. 2003), SimL (Luft et al. 2005; 
Pacholec et al. 2005a), Orf4 and RubC1 (Boll et al. 2011) (see chapter 6). The ATP-
dependent reaction indicates an activation of the carboxy group of the acyl moiety via 
adenylation. While the amide synthetase activity could already be shown in 1975 in 
cell extracts of S. niveus (Kominek and Meyer 1975), the reaction mechanism was 
initially approved in 2000 by identification and characterization of NovL via an PPi-
ATP exchange assay (Steffensky et al. 2000b). After formation of an acyl-AMP-
intermediate the acyl group is transferred to the amino group of the aminocoumarin 
ring (Fig. 2). Interestingly, coumermycin A1 contains two amide bonds and the 
formation of both is catalyzed by CouL. Analysis of the two reaction products of CouL 
proved that they represent a monoamide and the diamide of 3-methylpyrrole-2,4-
dicaboxylic acid and the aminocoumarin ring. Therefore, CouL is capable of 
catalyzing four enzymatic steps, i.e. two adenylation and two acyl transfer reactions, 
resulting in the formation of two amide bonds (Schmutz et al. 2003). 
The different amide synthetases have varying substrate specificities and 
recently a high-throughput screening was established that allows fast creation and 
testing of amide synthetases with altered substrate specificity (Parajuli and Williams 
2011). These distinctions in substrate specificity have been exploited and various 
acyl substrates have been offered to the amide synthetases. Because the acyl moiety 
of novobiocin and clorobiocin is of no importance for binding to the gyrase (Lafitte et 
al. 2002), a multiplicity of new aminocoumarin antibiotics have been generated by 
biochemical, genetic, and synthetic mutasynthesis in genetically engineered producer 
strains (Alt et al. 2011; Anderle et al. 2007; Galm et al. 2004a). Some of the 
aminocoumarin derivatives exhibited a higher inhibition of gyrase (Galm et al. 2004b) 
and derivatives with a catechol group showed improved uptake by bacteria (Alt et al. 
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2011). Therefore, amide synthetases represent an important tool in the 
chemoenzymatic generation of new antibiotics. 
 
4.2 Non-ribosomal peptide synthetases 
Non-ribosomal peptide synthetases (NRPS) are class I enzymes of adenylate-
formation (Schmelz and Naismith 2009). They catalyze the formation of an amide 
bond between amino acids independent of the ribosome.  
The first NRPS was identified in the biosynthesis of the cyclic decapeptide 
gramicidin S from Bacillus brevis, which activates the amino acids and tethers them 
one by one covalently to the NRPS (Gevers et al. 1968; Gevers et al. 1969; Kleinkauf 
et al. 1969). 
 
Figure 3 Schematic representations of NRPSs on the example of (1) NovH from novobiocin 
biosynthesis and (2) CepA and (3) CepC from vancomycin biosynthesis. (A) adenylation 
domain; (PCP) peptidyl carrier domain; (C) condensation domain; (E) epimerization domain; 
(TE) thioester domain. 
Today many cyclic and linear peptides of medical and pharmaceutical 
importance are known to be biosynthesized by NRPS enzymes (Felnagle et al. 
2008). Intensive studies revealed that these large enzymes often comprise different 
modules which again are divided in distinct domains (Fig. 3) (Marahiel and Essen 
2009; Marahiel et al. 1997). Each domain assumes a certain function in the linking of 
amino acids. The adenylation domain (A) activates an amino acid (Turgay et al. 
1992) and tethers it covalently to the phosphopantheteinyl cofactor of the peptidyl 
carrier domain (PCP) (Stachelhaus et al. 1996). The PCP domain transfers the amino 
acid to the condensation (C) domain where a condensation with a second amino acid 
occurs (Stachelhaus et al. 1998). In some NRPS an epimerization domain isomerizes 
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the amino acid from one stereochemistry to the other. During biosynthesis the amino 
acids remain covalently bound to the NRPS. For cleavage of the covalent thioester 
bond between PCP domain and substrate, some NRPS contain a thioesterase. For 
increased diversity the NRPS can contain additional modules for further modifications 
such as methylation or cyclization (Konz and Marahiel 1999). Furthermore, the NRPS 
can be part of a bigger hybrid enzyme that contains a polyketide synthetase (PKS). 
Bioinformatic studies of NRPS A-domains has led to the identification of a specificity-
conferring code, which consists of approximately ten amino acid residues that line the 
substrate-binding pocket of the respective enzyme. This code allows the prediction of 
the specific amino acid that is adenylated by each A-domain (Challis et al. 2000; 
Stachelhaus et al. 1999).  
By structure determination of single NRPS domains as well as X-ray and NMR 
studies of the interaction between different NRPS domains, especially the interaction 
between A and PCP domain (Yonus et al. 2008), new insights into NRP synthesis 
were gained. These findings allow the alteration of substrate specificity, domain 
swapping and NRPS re-engineering to broaden the range of secondary metabolites. 
 
5. Vancomycin and glycopetide antibiotics 
The class of glycopeptide antibiotics comprises a plethora of different 
compounds, all synthesized by Actinomycetes. Vancomycin is the most prominent 
representative of the class of glycopeptide antibiotics and was also the first member 
of this family discovered and isolated in the 1950s at Eli Lilly from Streptomyces 
orientalis (now Amycolatopsis orientalis) (Levine 2006). Shortly after its discovery the 
US Food and Drug Administration approved vancomycin for clinical use. Until today 
these antibiotics are of major importance for the treatment of infectious diseases 
particularly methicillin-resistant Staphylococcus aureus (MRSA). Glycopeptides are 
drugs of last resort because of their cumbersome intravenously application, side 
effects like ototoxicity, nephrotoxicity and red man syndrome (Levine 2006), and 
because semi-synthetic penicillins such as methicillin, nafcillin or cloxacillin exhibit 
better activity against non-MRSA staphylococci. Glycopeptides are not active against 
Gram-negative bacteria because their outer membrane is impermeable to large 
glycopeptide molecules (except some non-gonococcal species of Neisseria (Geraci 
and Wilson 1981)). 
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Glycopeptides target the cell wall biosynthesis of Gram-positive bacteria via 
interaction with the pentapetide on GlucNAc-MurNAc which is a precursor of 
peptidoglycan. The large hydrophilic molecule is able to bind to the terminal D-alanyl-
D-alanine moieties of the peptidoglycan precursors by forming five hydrogen bonds 
with the amide bonds and C-terminus of the target (Nicolaou et al. 1999). This results 
in inhibition of the transpeptidation steps of peptidoglycan synthesis and thereby 
weakens the peptidoglycan layers (Kahne et al. 2005). Additionally, telavancin and 
oritavancin are able to disrupt bacterial membrane integrity and thereby increase 
membrane permeability (Zhanel et al. 2010). In the 1990s vancomycin-resistant 
enterococci and staphylococci spread in clinics (Nicolaou et al. 1999). These 
resistant enterococci either use peptidoglycan precursors terminated in D-Ala-D-Lac 
(VanA/VanB resistance) or less effectively D-Ala-D-Ser (VanC resistance) peptides 
for cell wall biosynthesis (Bugg et al. 1991; Pootoolal et al. 2002). This results in a 
~1000-fold lower affinity for glycopeptides (Kahne et al. 2005). However, an aglycon 
derivative was created recently that is able to bind D-Ala-D-Ala as well as D-Ala-D-
Lac motifs with good affinity (Xie et al. 2011). 
 
Figure 4 Vancomycin and related glycopeptides consisting of a crosslinked heptapetide 
backbone. Vancomycin: R1= vancosamine; R2= H; Balhimycin: R1= H ; R2= oxovancosamine ; 
Chloroeremomycin: R1 and R2= epivancosamine. 
The biosynthesis of glycopeptides such as vancomycin (van Wageningen et al. 
1998), balhimycin (Pelzer et al. 1999) and teicoplanin (Li et al. 2004; Sosio et al. 
2004) were the aim of intensive studies and most biosynthetic steps of these 
molecules have been elucidated. All glycopeptides are comprised of seven amino 
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acids forming a heptapetide backbone (Fig. 4). They are assembled via non-
ribosomal peptide synthases (NRPS). The biosynthesis itself can be divided into 
three phases. First, the synthesis of non-proteinogenic amino acids as building 
blocks. This precedes the assembly of the building blocks by NRPS to a linear 
heptapetide backbone (Pelzer et al. 1999; Süssmuth et al. 1999) and interlinking of 
the aromatic side chains. This assembly starts with recognition and activation of the 
respective amino acid by the adenylation domain of the NRPS, followed by thioester 
formation and subsequent condensation with the growing peptide chain. From 
observations in balhimycin biosynthesis is was concluded that the chlorination takes 
place on NRPS-bound intermediates and not on the free heptapeptide (Wohlleben et 
al. 2009). After the linear heptapeptide backbone is synthesized, glycopeptides 
undergo further modifications. This third step involves oxidative cross-linking 
(Bischoff et al. 2001) of the heptapetide and modification by glycosyltransferases 
(Chen et al. 2000) and a methyltransferase (O'Brien et al. 2000). Some derivatives 
additionally utilize acyltransferases and sulfotransferases (Lamb et al. 2006). 
The vancomycin-type glycopeptides consist of two proteinogenic (Leu and Asn) 
and five non-proteinogenic amino acids, namely two β-hydroxytyrosines, two 3-
hydroxyphenylglycins and a 3,5-dihydroxyphenylglycine (Fig. 4). The β-
hydroxytyrosine is derived from L-tyrosine which is adenylated by a NRPS and then 
bound to its PCP domain. Subsequently, a monooxygenase catalyzes the β-
hydroxylation of the NRPS bound L-tyrosine. This is very similar to the first steps of 
aminocoumarin biosynthesis (Chen and Walsh 2001; Puk et al. 2004). Here however, 
the product is cleaved from the PCP domain after β-hydroxylation by a thioesterase 
to be assembled by a different NRPS in the heptapeptide backbone (Mulyani et al. 
2010). The β-hydroxylation of L-tyrosine and the influence of MbtH-like proteins on 
this reaction is the center of the investigation in chapter 7. The various vancomycin-
like glycopeptides differ only in their glycosylation, methylation and chlorination 
patterns (Stegmann et al. 2010). Teicoplanin-like glycopeptides also consist of seven 
aminoacids but differ in their residues as well as in their aromatic cross-linking and 
further modifications. 
Since glycopeptides have a similar structure they are good scaffolds for genetic 
engineering, combinatorial biosynthesis and chemoenzymatic modification. The 
extensive available knowledge about their biosynthesis allows alterations of the post-
translational modifications or substitution of amino acids in the backbone (Weist et al. 
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2002; Weist et al. 2004), and leads to new antibiotics and new secondary 
metabolites. 
 
6. MbtH-like proteins 
The gene mbtH was found in Mycobacterium tuberculosis in the biosynthetic 
gene cluster of the virulence-conferring siderophore mycobactin (Quadri et al. 1998). 
It encodes a small protein with 71 amino acids. Subsequent studies showed that 
mbtH-like genes are often found in gene clusters containing NRPS domains for 
biosynthesis of antibiotics or siderophores. 
The mbtH-like genes are exclusively found in bacteria but neither in Archaea 
nor Eukaryota and until now there are more than 400 mbtH homologs annotated in 
GenBank. MbtH homologs are most prevalent within the Actinobacteria with 188 
homologs, among them 65 in Streptomycetes (Baltz 2011). Some genomes contain 
several mbtH-like genes and the largest number so far were observed in 
Streptomyces clavigulerus and Streptomyces griseus, which both contain seven 
mbtH homologs. 
In Actinomycetes, mbtH-like genes are generally located in gene clusters of 
secondary metabolites encoding the biosynthesis of non-ribosomal peptides 
including the antibiotics vancomycin, daptomycin, teicoplanin, capreomycin as well as 
the aminocoumarin antibiotics clorobiocin and coumermycin A1. Interestingly, the 
aminocoumarin biosynthetic gene clusters contain only one NRPS gene with an 
adenylation domain (A) and a peptidyl carrier domain (PCP) that is involved in the 
activation and binding of L-tyrosine (Chen and Walsh 2001). The mbtH-like gene in 
the clusters of clorobiocin and coumermycin A1 is directly adjacent to the NRPS gene 
similar to the nikP1 of nikkomycin where the mbtH-like gene is fused to the A-PCP 
gene into one open reading frame (Chen et al. 2002). The role and function of MbtH-
like proteins in the biosynthesis of aminocoumarin and glycopeptide antibiotics like 
vancomycin is elucidated in chapter 7. 
Gene inactivation studies of the mbtH-like gene dptG from the biosynthetic gene 
cluster of daptomycin showed a 50 % reduction in yield (Nguyen et al. 2006). 
However, production was not completely abolished and it is unknown if this is due to 
cross-pathway complementation of DptG by another MbtH-like protein in S. 
roseosporus. The same problem appeared in another study about MbtH-like proteins 
in the biosynthesis of balhimycin by Stegmann and coworkers (2006). The mbtH-like 
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gene orf1 in A. balhimycina was inactivated but no effect on the balhimycin 
production could be observed. However, the authors mentioned that the genome 
contains two other mbtH-like genes that could take over the function of orf1 
(Stegmann et al. 2006). 
First proof that these genes are essential for secondary metabolite production 
was provided by two studies about gene inactivation and complementation in the 
biosynthesis of clorobiocin (Wolpert et al. 2007), coelichelin and calcium-dependent 
antibiotic (Lautru et al. 2007). They proved that the gene products of cdaX from the 
calcium dependent antibiotic cluster, cchK from the coelichelin cluster and cloY from 
the clorobiocin cluster could complement each other to some extent. A strain where 
all mbtH homologs have been deleted was unable to produce the respective 
compound.  
 
 
Figure 5 Structures of PA2412 (blue) and MbtH (red). The three conserved tryptophans are 
displayed in orange. 
Two structures of MbtH-like proteins have been determined: PA2412 from the 
pyoverdine cluster of Pseudomonas aeruginosa via crystallization (Drake et al. 2007) 
and the name-giving MbtH by using magnetic resonance and circular dichroism 
spectroscopy (Buchko et al. 2010). PA2412 is shaped like a thin arrowhead with 
three anti-parallel β-sheets followed by two α-helices, one nestled against the β-
sheet and the second on the C-terminus forming the point of the arrow (Fig. 5) (Drake 
et al. 2007). The solution structure is similar to the aforementioned crystal structure 
Chapter 3 Introduction
 
Page 21  
 
except for the C-terminus which is highly disordered in the second case (Fig. 5). The 
authors hypothesized that highly conserved but disordered regions as in the C-
terminus are associated with binding to multiple partners. This might explain the 
promiscuity of MbtH-like proteins and the cross-talk between different MbtH-like 
proteins. For the second ordered helix observed in the PA2412 crystal structure it 
was speculated that this occurs due to crystal packing interactions or the binding of 
an unknown small ligand (Buchko et al. 2010). Sequence comparison of stand-alone 
MbtH-like proteins showed invariant regions, highly conserved regions and variable 
regions. The conserved residues, including the three highly conserved tryptophans 
(in MbtH W26, W36 and W56) all lie on one face of the protein. The localization of 
invariant residues on one face and variable on the other side suggests the interaction 
with two types of protein. Finally, both structures show no obvious active site of 
MbtH-like proteins. 
Recent biochemical studies of MbtH-like proteins from Actinomycetes revealed 
their function. It was shown that MbtH-like proteins interact with adenylating enzymes 
which are part of NRPSs. The biosynthetic gene clusters of the antituberculosis 
antibiotics capreomycin from Saccharothrix mutabilis subsp. capreolus (Felnagle et 
al. 2007) and viomycin produced by Streptomyces sp. ATCC 11861 (Thomas et al. 
2003) both contain an mbtH-like (cmnN and vioN) gene just upstream of a NRPS 
domain (cmnO and vioO). CmnO and VioO alone showed no adenylation activity with 
β-lysine or any other amino acid but the addition of CmnN or VioN resulted in the 
activation of β-lysine (Felnagle et al. 2010). Another study with the mbtH-like gene 
pacJ from the biosynthetic gene cluster for pacidamycin from Streptomyces 
coeruleorubidus (Zhang et al. 2010b) with the NRPS domains showed the same 
results. PacJ activated the NRPS protein PacL which was inactive alone (Zhang et al. 
2010a). Both studies showed that the specific MbtH-like proteins could be substituted 
by homologs from different pathways, e.g. YbdZ from E. coli siderophore 
biosynthesis or KtzJ from kutzneride biosynthesis. To further explore the MbtH-NRPS 
interaction both groups performed site-directed mutagenesis with the three 
conserved tryptophan residues. The change of W56 to alanine (in reference to MbtH) 
resulted in protein that could neither be copurified nor stimulate the amino acid 
activation (Felnagle et al. 2010). The substitution of the corresponding residue W26 
in MbtH led to a 50 % reduction of stimulated adenylation activity while the 
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substitution of W26 and W36 showed no stimulatory effect and the mutated protein 
was unable to bind to the NRPS enzyme (Zhang et al. 2010a). 
The recent studies, including the one in chapter 7, showed that MbtH-like 
proteins are required for the adenylation of amino acids in non-ribosomal peptide 
synthesis. While it still remains unclear how they interact with NRPS, MbtH-like 
proteins are important for several applications. Since most important NRPS pathways 
include mbtH-like genes, they could serve as beacons for the identification of new 
bacterial strains to produce novel peptides (Baltz 2011). Furthermore, MbtH-like 
proteins play an important role in strain improvement, combinatorial biosynthesis and 
heterologous expression. Some NRPS domains are strictly dependent on MbtH-like 
proteins and are stimulated at different rates by various MbtH homologs. Therefore it 
is crucial for the success of such experiments to include the correct mbtH-like genes 
for the expression of NRPS gene clusters. 
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Abstract 
The bacterium Streptomyces anulatus 9663, isolated from the intestine of different 
arthropods, produces prenylated derivatives of phenazine 1-carboxylic acid. From 
this organism, we have identified the prenyltransferase gene ppzP. ppzP resides in a 
gene cluster containing orthologs of all genes known to be involved in phenazine 1-
carboxylic acid biosynthesis in Pseudomonas strains as well as genes for the six 
enzymes required to generate dimethylallyl diphosphate via the mevalonate pathway. 
This is the first complete gene cluster of a phenazine natural compound from 
streptomycetes. Heterologous expression of this cluster in Streptomyces coelicolor 
M512 resulted in the formation of prenylated derivatives of phenazine 1-carboxylic 
acid. After inactivation of ppzP, only nonprenylated phenazine 1-carboxylic acid was 
formed. Cloning, overexpression, and purification of PpzP resulted in a 37-kDa 
soluble protein, which was identified as a 5,10-dihydrophenazine 1-carboxylate 
dimethylallyltransferase, forming a C–C bond between C-1 of the isoprenoid 
substrate and C-9 of the aromatic substrate. In contrast to many other 
prenyltransferases, the reaction of PpzP is independent of the presence of 
magnesium or other divalent cations. The Km value for dimethylallyl diphosphate was 
determined as 116 μM. For dihydro-PCA, half-maximal velocity was observed at 35 
μM. Kcat was calculated as 0.435 s-1. PpzP shows obvious sequence similarity to a 
recently discovered family of prenyltransferases with aromatic substrates, the ABBA 
prenyltransferases. The present finding extends the substrate range of this family, 
previously limited to phenolic compounds, to include also phenazine derivatives. 
 
Introduction 
The transfer of isoprenyl moieties to 
aromatic acceptor molecules gives rise 
to an astounding diversity of secondary 
metabolites in bacteria, fungi, and 
plants, including many compounds that 
are important in pharmacotherapy. 
However, surprisingly little biochemical 
and genetic data are available on the 
enzymes catalyzing the C-prenylation of 
aromatic substrates. Recently, a new 
family of aromatic prenyltransferases 
was discovered in streptomycetes (1), 
Gram-positive soil bacteria that are 
prolific producers of antibiotics and other 
biologically active compounds (2). The 
members of this enzyme family show a 
new type of protein fold with a unique α-
β-β-α architecture (3) and were therefore 
termed ABBA prenyltransferases (1). 
Only 13 members of this family can be 
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identified by sequence similarity 
searches in the data base at present, 
and only four of them have been 
investigated biochemically (3-6). Up to 
now, only phenolic compounds have 
been identified as aromatic substrates of 
ABBA prenyltransferases. We now 
report the discovery of a new member of 
the ABBA prenyltransferase family, 
catalyzing the transfer of a dimethylallyl 
moiety to C-9 of 5,10-dihydrophenazine 
1-carboxylate (dihydro-PCA).2 
Streptomyces strains produce many of 
prenylated phenazines as natural 
products. For the first time, the present 
paper reports the identification of a 
prenyltransferase involved in their 
biosynthesis. 
Streptomyces anulatus 9663, 
isolated from the intestine of different 
arthropods, produces several prenylated 
phenazines, among them 
endophenazine A and B (Fig. 1A) (7). 
We wanted to investigate which type of 
prenyltransferase might catalyze the 
prenylation reaction in endophenazine 
biosynthesis. In streptomycetes and 
other microorganisms, genes involved in 
the biosynthesis of a secondary 
metabolite are nearly always clustered in 
a contiguous DNA region. Therefore, the 
prenyltransferase of endophenazine 
biosynthesis was expected to be 
localized in the vicinity of the genes for 
the biosynthesis of the phenazine core 
(i.e. of PCA). 
In Pseudomonas, an operon of 
seven genes named phzABCDEFG is 
responsible for the biosynthesis of PCA 
(8). The enzyme PhzC catalyzes the 
condensation of phosphoenolpyruvate 
and erythrose-4-phosphate (i.e. the first 
step of the shikimate pathway), and 
further enzymes of this pathway lead to 
the intermediate chorismate. PhzD and 
PhzE catalyze the conversion of 
chorismate to 2-amino-2-
deoxyisochorismate and the subsequent 
conversion to 2,3-dihydro-3-
hydroxyanthranilic acid, respectively. 
These reactions are well established 
biochemically. Fewer data are available 
about the following steps (i.e. 
dimerization of 2,3-dihydro-3-
hydroxyanthranilic acid, several 
oxidation reactions, and a 
decarboxylation, ultimately leading to 
PCA via several instable intermediates). 
From Pseudomonas, experimental data 
on the role of PhzF and PhzA/B have 
been published (8,9), whereas the role 
of PhzG is yet unclear. Surprisingly, the 
only gene cluster for phenazine 
biosynthesis described so far from 
streptomycetes (10) was found not to 
contain a phzF orthologue, raising the 
question of whether there may be 
differences in the biosynthesis of 
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phenazines between Pseudomonas and 
Streptomyces. 
Screening of a genomic library of 
the endophenazine producer strain S. 
anulatus now allowed the identification 
of the first complete gene cluster of a 
prenylated phenazine, including the 
structural gene of dihydro-PCA 
dimethylallyltransferase. 
 
Experimental Procedures 
Bacterial Strains, Plasmids, and 
Culture Conditions 
S. anulatus 9663 has been isolated 
previously from the intestine of different 
arthropods (7,11). It was grown in liquid 
YMG medium or on solid MS medium. 
For production of secondary 
metabolites, the medium described by 
Sedmera et al. (12) was used. 
Escherichia coli XL1 Blue MRF, E. 
coli SURE (Stratagene, Heidelberg, 
Germany), E. coli BW 25113, and E. coli 
ET 12567 (pUB307) were used for 
cloning and were grown in liquid or on 
solid (1.5 % agar) Luria-Bertani or SOB 
medium at 37 °C. The REDIRECT 
technology kit for PCR targeting was 
obtained from Plant Bioscience Limited 
(Norwich, UK). For inactivation 
experiments, the aac(3)IV/oriT 
(apramycin resistance) cassette from 
pIJ773 (13) was used. Carbenicillin (50–
100 μg ml-1), apramycin (50 μg ml-1), 
kanamycin (50 μg ml-1), chloramphenicol 
(25 μg ml-1), and nalidixic acid (20 μg ml-
1) were used for selection of 
recombinant strains. 
 
Chemicals 
Kanamycin and carbenicillin were 
purchased from Genaxxon BioSciences 
GmbH (Biberach, Germany); apramycin 
and nalidixic acid were from Sigma; 
chloramphenicol was from Merck; and 
phenazine 1-carboxylic acid was from 
InFormatik. Dimethyllallyl diphosphate 
was synthesized as described by 
Woodside et al. (14). Endophenazine A 
was isolated from cultures of 
Streptomyces cinnamonensis DSM 1024 
as described by Gebhardt et al. (7). 
 
Genetic Procedures 
Standard methods for DNA isolation and 
manipulation were performed as 
described by Kieser et al. (15) and 
Sambrook et al. (16). DNA fragments 
were isolated from agarose gels by 
using a PCR purification kit (Amersham 
Biosciences). Genomic DNA was 
isolated from Streptomyces strains by 
lysozyme treatment and 
phenol/chloroform extraction as 
described by Kieser et al. (15). 
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Construction and Screening of the 
Cosmid Library 
Chromosomal DNA from S. anulatus 
was partially digested with Sau3AI, 
dephosphorylated and then ligated into 
the BamHI sites of SuperCos 1 
(Stratagene) according to the 
manufacturer's instructions. The ligation 
products were packaged with Gigapack 
III XL (Stratagene) and transduced into 
E. coli SURE. Colony hybridization was 
performed on Hybond-N membranes 
(Amersham Biosciences). ephzA from S. 
cinnamonensis (10) was used as 
hybridization probe for the first screening 
of the library. The digoxigenin-labeled 
ephzA was generated using the PCR 
digoxigenin labeling mix (Roche Applied 
Science) with the primers ephzA_for (5′-
ATG AGC ACC CCC CTG ACC ACC-3′) 
and ephzA_rev (5′-TCA GGA GGG GAT 
CCA GTC CCG-3′). 
A second screening was performed 
by PCR for the identification of the 
following genes: phzD, phzF, hmgr (3-
hydroxy-3-methyl-glutaryl-CoA 
reductase), hmgs (3-hydroxy-3-
methylglutaryl-CoA synthase), and mdpd 
(mevalonate diphosphate 
decarboxylase). The following primers 
were used: phzD_for (5′-CGC GCC GTC 
CTG (A/G)TN CA(C/T) GA(C/T) 
(A/C/T)T-3′) and phzD_rev (5′-CGG 
TGG TGG TCC CGG (G/C)(A/T)(A/G) 
AA(A/G) TCN (G/C)-3′); phzF_for (5′-
CAT CCG GAT CTT GAC CCC NGT 
NAA (C/T)GA-3′) and phzF_rev (5′-GAG 
GGG CGC CCC AT(C/T) TCN CAN CC-
3′); HMGR_for (5′-GGG CAT CGC CGC 
GAC CCT CGT GGA GGA GGG-3′) and 
HMGR_rev (5′-GCG ATG ACG GGG 
AGG CGC CGG GCG TTC TC-3′); 
HMGS_for (5′-GCC AAG TCC GCC 
GGN GTN TA(C/T) GT-3′) and 
HMGS_rev (5′-AGC CGG AAG GGG 
CCN GTN GT(C/T) TG-3′); MDPD_for 
(5′-GAC CCT GGA CGT CTT CCC NAC 
NAC NAC-3′) and MDPD_rev (5′-GCG 
TTC CGC TCG GC(A/G/T) AT(C/T) 
TCN-3′). PCRs were carried out with 
Taq polymerase. 
 
Heterologous Expression of Cosmids 
ppzOS04 and ppzOS02 
The plasmid pIJ787 (17) was first 
digested with DraI and BsaI, and the 
4990-bp fragment containing the 
integrase cassette was used to replace 
the bla gene in the SuperCos 1 
backbone in cosmids 11C7 and 18A9, 
using λ RED-mediated recombination 
(17,18), generating ppzOS02 and 
ppzOS04, respectively. Both cosmids 
were first transformed into the 
nonmethylating host E. coli ET12567, 
and the nonmethylated DNA was 
introduced into Streptomyces coelicolor 
M512 via triparental conjugation. 
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Inactivation of the Gene ppzP 
An apramycin resistance cassette 
(aac(3)IV) was amplified from plasmid 
pUG019 (19) using the following 
primers: ppzP_F (5′-CGC CCC AAG 
GGT GTC TTG TCG ACC TGT GGA 
GGA AAA ATG TCT AGA ATT CCG 
GGG ATC CGT CGA CC-3′) and 
ppzP_R (5′-CAA GCC CTT GTC CTT 
CAC ATG CCG ACG GGT GAG GCG 
CTA ACT AGT TGT AGG CTG GAG 
CTG CTT C-3′). Underlined are 
restriction sites for XbaI and SpeI, used 
for later removal of the cassette. The 
resulting 1077-bp PCR product was 
used to replace the ppzP gene on 
cosmid ppzOS04 by λ RED-mediated 
recombination, resulting in cosmid 
ppzOS05. Deletion of the aac(3)IV 
cassette from ppzOS05 was carried out 
by digestion with XbaI and SpeI and 
religation, resulting in cosmid ppzOS09. 
The resulting construct was introduced 
into S. coelicolor M512 via triparental 
conjugation (15). 
 
Production and Analysis of 
Secondary Metabolites 
Exconjugants of all mutants as well as 
wild type S. anulatus were precultured 
for 48 h in liquid YMG medium (50 ml). 
50 ml of production medium (20) was 
then inoculated with 2.5 ml of the 
precultures. The flasks were agitated on 
a rotary shaker at 30 °C and 200 rpm for 
120 h. For cultivation of mutants, all 
liquid media contained kanamycin (50 
μg ml-1). 
For isolation of endophenazine A, 
mycelia from 50-ml cultures were 
centrifuged at 3500 × g for 10 min. The 
supernatant was discarded, and the 
cells were extracted with methanol (10 
ml) by vortexing. The extract was mixed 
with sodium acetate buffer (10 ml; 1 M, 
pH 4.0) and extracted with 
dichloromethane (5 ml). After separation 
of the organic phase, the solvent was 
evaporated, and the residue was 
redissolved in methanol (0.5 ml). 
Extracts were analyzed with HPLC 
(Agilent 1100 series; Waldbronn, 
Germany) by using an Eclipse XDB-C18 
column (4.6 × 150 mm, 5 μm; Agilent) at 
a flow rate of 1 ml min-1 with a linear 
gradient from 10 to 100 % of solvent B in 
20 min (solvent A: water/phosphoric acid 
(999:1); solvent B, acetonitrile) and 
detection at 252 and 365 nm. 
Additionally, a UV spectrum from 200 to 
400 nm was logged by a photodiode 
array detector. The absorbance at 365 
nm was used for quantitative analysis, 
employing authentic reference samples 
of PCA and endophenazine A as 
external standards. 
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Analysis by LC-MS 
The extracts were examined with LC-MS 
and LC-MS2 analysis using a Nucleosil 
100-C18 column (3 μm, 100 × 2 mm) 
coupled to an ESI mass spectrometer 
(LC/MSD Ultra Trap System XCT 6330; 
Agilent Technology). Analysis was 
carried out at a flow rate of 0.4 ml min-1 
with a linear gradient from 10 to 100 % 
of solvent B in 15 min (solvent A: 
water/formic acid (999:1); solvent B: 
acetonitrile/formic acid (999.4:0.6)). 
Detection was carried out at 230, 260, 
280, 360, and 435 nm. Electrospray 
ionization (positive and negative 
ionization) in Ultra Scan mode with 
capillary voltage of 3.5 kV and heated 
capillary temperature of 350 °C was 
used for LC-MS analysis. For LC-MS2 
and LC-MS3, the analysis was carried 
out in positive ionization mode with 
capillary voltage of 3.5 kV at 350 °C. For 
LC-MS2 identification of the enzymatic 
product endophenazine A, the mass 293 
± 0.5 Da was selected for fragmentation. 
In LC-MS3, the mass 275 ± 1 Da was 
selected for fragmentation. 
 
Overexpression and Purification of 
PpzP Protein 
ppzP was amplified by using the primers 
ppzP_pHis_F (5′-ACC TGT GGA GAA 
TTC ATG TCA GAA TCC GCT GAG 
CT-3′) and ppzP_pHis_R (5′-CCG GAC 
GGG CTC GAG GCT ATC CGG CAT 
CGG CGG TCA-3′). The underlined 
letters represent EcoRI and XhoI 
restriction sites, respectively. The 
resulting PCR fragment was digested 
with EcoRI and XhoI and ligated into 
plasmid pHis8 (21) digested with the 
same restriction enzymes. The resulting 
plasmid, pHis8-OS01, was verified by 
restriction mapping and sequencing. 
E. coli BL21(DE3)pLysS cells 
harboring plasmid pHis8-OS01 were 
cultivated in 2 liters of liquid TB medium 
containing 50 μg ml-1 kanamycin and 
grown at 37 °C to an A600 of 0.6. The 
temperature was lowered to 20 °C, and 
isopropyl 1-thio-β-d-galactopyranoside 
was added to a final concentration of 0.5 
mM. The cells were cultured for a further 
10 h at 20 °C and harvested. 30 ml of 
lysis buffer (50 mM Tris-HCl, pH 8.0, 1 
M NaCl, 10% glycerol, 10 mM β-
mercaptoethanol, 20 mM imidazole, 0.5 
mg ml-1 lysozyme, 0.5 mM 
phenylmethylsulfonyl fluoride) were 
added to the pellet (40 g). After stirring 
at 4 °C for 30 min, cells were ruptured 
with a Branson sonifier by 4 °C. The 
lysate was centrifuged (55,000 × g, 45 
min). Affinity chromatography with 4 ml 
of Ni2+-nitrilotriacetic acid-agarose resin 
(Qiagen, Hilden, Germany) was carried 
out according to the manufacturer's 
instructions, using 2 × 2.5 ml of 250 mM 
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imidazole (in 50 mM Tris-HCl, pH 8.0, 1 
M NaCl, 10% glycerol, 10 mM β-
mercaptoethanol) for elution. 
Subsequently, a buffer exchange was 
carried out by PD10 columns 
(Amersham Biosciences), which were 
eluted with 50 mM Tris-HCl, pH 8.0, 1 M 
NaCl, 10% glycerol, and 2 mM 1,4-
dithiothreitol. Approximately 30 mg of 
purified PpzP were obtained from 2 liters 
of cultures. 
 
Assay for Prenyltransferase Activity 
The reaction mixture (100 μl) contained 
80 mM Na-TAPS (pH 7.5) (Sigma), 0.8 
mM freshly prepared dihydro-PCA, 0.4 
mM dimethylallyl diphosphate (DMAPP), 
500 mM NaCl, and 5 μg ml-1 PpzP. For 
the preparation of dihydro-PCA, 90 μl of 
100 mM freshly dissolved sodium 
dithionite (Merck) were mixed with 10 μl 
of 100 mM PCA dissolved in Tris-HCl, 
pH 8.0. 8 μl of this mixture was added to 
the incubation mixture. After incubation 
for 20 or 30 min at 30 °C, 15 μl of 100 
mM sodium persulfate (Sigma) were 
added to oxidize dihydro-PCA and 
dihydroendophenazine A into PCA and 
endophenazine A, respectively. The 
mixture was immediately extracted with 
100 μl of ethyl acetate/formic acid 
(975:25). After vortexing and 
centrifugation, 75 μl of the organic 
phase were evaporated. The residue 
was dissolved in 100 μl of methanol, and 
35 μl thereof were analyzed by HPLC 
using an Eclipse XDB-C18 column (4.6 
× 150 mm, 5 μm; Agilent) with the same 
mobile phase and gradient described 
above for secondary metabolite 
analysis. Detection was carried out at 
252 and 365 nm. Quantitative analysis 
was carried out using the absorbance at 
365 nm, as described under “Production 
and Analysis of Secondary Metabolites.” 
 
Calculation of Kinetic Constants 
Km and Kcat were calculated using the 
GraphPad Prism software, version 5.01 
for Windows (GraphPad Software Inc., 
La Jolla, CA). 
 
Results 
Cloning of a Biosynthetic Gene 
Cluster for Prenylated Phenazines 
A genomic library of the phenazine 
producer strain S. anulatus was 
constructed in cosmid vector SuperCos 
1 (Stratagene). 2000 independent 
cosmid clones were subjected to a 
colony blot screening with a labeled 
probe of the phenazine biosynthesis 
gene ephzA from S. cinnamonensis 
(10). From the genome size of 
streptomycetes (∼8.5 megabases) and 
the average insert size of SuperCos 1 
(∼38 kb), it could be estimated that a 
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single genome locus would be 
represented, on average, in nine 
different cosmid clones. However, the 
screening revealed 26 positive clones, 
indicating that more than one genomic 
locus hybridized with ephzA. In order to 
identify those cosmids that contained the 
correct locus and that were likely to 
contain the entire gene cluster, these 26 
cosmids were screened with degenerate 
primers for two further phenazine 
biosynthetic genes, phzD and phzF, and 
for three genes of the mevalonate 
pathway for isoprenoid biosynthesis (see 
“Experimental Procedures”). In another 
Streptomyces strain, it had been shown 
that the prenyl moiety of endophenazine 
A is formed via the mevalonate pathway 
(22), whereas in streptomycetes, the 
methyl erythritol phosphate pathway is 
used for the formation of isoprenoids of 
primary metabolism (23). Two cosmids, 
18A9 and 11C7, were identified that 
gave PCR products with all five primer 
pairs. Sequencing of the PCR products 
confirmed that they represented phzD, 
phzF, and the three mevalonate 
pathway genes. Sequencing of cosmid 
18A9 revealed a DNA region of 17.5 kb 
comprising 18 putative coding 
sequences (Fig. 1B), which together 
code for all enzymatic functions 
expected to be involved in 
endophenazine formation. The results of 
data base comparisons for these genes 
are listed in Table 1. Seven of the 
putative coding sequences, designated 
as ppzA, ppzC, ppzD, ppzE, ppzF, 
ppzG, and ppzB, showed obvious 
similarities to the seven genes that direct 
the biosynthetic pathway from 
phosphoenolpyruvate and erythrose-4-
phosphate to PCA in Pseudomonas 
strains (8,9). In addition, the gene ppzM 
was identified, showing striking similarity 
to phzM from P. aeroginosa. phzM is 
proposed to be responsible for the N-
methylation in the biosynthesis of 
pyocyanine (1-hydroxy-5-N-
methylphenazine) (24). ppzM may 
therefore be responsible for the N-
methylation reaction in the biosynthesis 
of endophenazine B (Fig. 1A). 
Sequence analysis further revealed 
a group of six coding sequences with 
striking similarity to genes of the 
mevalonate pathway (23), leading from 
acetyl-CoA and acetoacetyl-CoA to 
isopentyl diphosphate and DMAPP (see 
Table 1). Orthologs of these six genes, 
arranged in the exact same order, are 
found in the biosynthetic gene cluster of 
furaquinocin (25), naphterpin (26), 
terepenticin (27), and BE 40644 (28). S. 
anulatus, therefore, is one of the rare 
Streptomyces species that possesses 
the genes of the mevalonate pathway, a 
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feature limited to ∼1% of the strains of 
this genus (29). 
 
TABLE 1: Genes in the endophenazine biosynthetic gene cluster of S. anulatus 9663 
Gene 
Amino 
acid 
Proposed function Ortholog identified by BLAST search 
Identity/ 
Similarity 
ppzP 299 Prenyltransferase Fnq26, S. cinnamonensis 44/64 
mk 345 Mevalonate kinase MEVK, Streptomyces sp. KO-3988 67/79 
mdp
d 
351 
Diphosphomevalonate 
decarboxylase 
MDPD, Streptomyces sp. KO-3988 73/80 
pmk 371 Phosphomevalonate kinase PMK, Streptomyces sp. KO-3988 68/75 
ippi 363 Isopentenyldiphosphate δ-isomerase Fni, Streptomyces sp. CL190 79/88 
hmgr 353 
3-Hydroxy-3-methylglutaryl 
coenzyme A reductase 
HMGR, Streptomyces sp. CL190 86/92 
hmgs 391 
3-Hydroxy-3-methylglutaryl CoA 
synthase 
HMGS, Streptomyces sp. CL190 78/87 
ppzT 327 
3-Oxoacyl-[acyl-carrier-protein] 
synthase 
3-Oxoacyl-[acyl-carrier-protein] 
synthase, Streptomyces sp. KO-3988 
79/86 
ppzU 221 Flavodoxin SGR_4078, Streptomyces griseus 59/75 
ppzV 206 Hypothetical protein Fnq22, S. cinnamonensis 62/77 
ppzM 340 N-Methyltransferase PhzM, Pseudomonas aeruginosa 44/58 
ppzB 168 Phenazine biosynthesis PhzB, Pseudomonas fluorescens 51/67 
ppzG 233 FMN-dependent oxidase PhzG, P. fluorescens 54/71 
ppzF 279 
trans-2,3-Dihydro 3-
hydroxyanthranilate isomerase 
PhzF, P. fluorescens 68/77 
ppzE 646 
2-Amino-2-desoxy-isochorismate 
synthase 
PhzE, P. fluorescens 60/76 
ppzD 207 
2,3-Dihydro-3-hydroxy-anthranilate 
(DHHA) Synthase 
PhzD, P. fluorescens 60/76 
ppzC 392 
3-Deoxy-d-arabino-heptulosonic acid 
7-phosphate synthase 
PhzC, P. fluorescens 59/73 
ppzA 162 Phenazine biosynthesis PhzA, P. fluorescens 78/87 
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Figure 1: A, prenylated phenazines from S. anulatus 9663. B, biosynthetic gene cluster of 
endophenazine A. 
 
Heterologous Expression of the 
Endophenazine Cluster in S. 
coelicolor M512 
λ RED-mediated recombination in E. coli 
was used to replace the β-lactamase 
gene within the SuperCos 1 backbone of 
cosmid 18A9 with the cassette pIJ787 
containing a tetracycline resistance gene 
and the integration function of the phage 
ΦC31 (13). The resulting cosmid 
ppzOS04 was introduced into the 
genome of S. coelicolor M512 using 
triparental conjugation (15). 
As control, the same pIJ787 
cassette was introduced in an empty 
SuperCos 1 vector, and the resulting 
construct, ppzOS30, was also integrated 
into the genome of S. coelicolor M512. 
The secondary metabolite production of 
the resulting integration mutants was 
analyzed by HPLC-UV and LC-MS, 
using the wild type strain S. anulatus as 
comparison. In accordance with 
previous results (7), S. anulatus was 
found to produce PCA and 
endophenazine A (Fig. 2A). The polar 
compound PCA was predominantly 
found in the culture medium, but some 
amount was also present in the mycelial 
extract. The more lipophilic, prenylated 
compounds endophenazine A and B 
were associated with the cells (i.e. were 
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mainly found in the pellet after 
centrifugation of the cultures). The 
heterologous expression strain S. 
coelicolor(ppzOS04) produced both 
phenazine 1-carboxylic acid (most of 
which was found in the medium) and 
endophenazine A (most of which was 
associated with the cells) (Fig. 2B). The 
presence of both compounds was also 
shown by LC-MS at m/z = 225 [M + H]+ 
and m/z = 293 [M + H]+ for PCA and 
endophenazine A, respectively. LC-MS2 
showed that both compounds had the 
same fragmentation pattern as the 
authentic reference samples (data not 
shown). In contrast, the control strain S. 
coelicolor M512(ppzOS30), which had 
integrated the empty vector, did not 
produce any phenazines (data not 
shown). 
 
 
Figure 2: HPLC analysis of cell extracts of different Streptomyces strains (detection: UV, 365 nm). A, 
wild-type S. anulatus. B, S. coelicolor M512 containing the complete endophenazine cluster from 
cosmid 18A9. C, S. coelicolor M512 containing a partial endophenazine cluster (cosmid 11C7; see 
Fig. 1). D, S. coelicolor M512 containing the complete endophenazine cluster (cosmid 18A9) but with 
deletion of the putative prenyltransferase gene ppzP. PCA, phenazine 1-carboxylic acid. The polar 
compound PCA is predominantly found in the culture medium, but varying amounts are also present in 
the mycelial extracts, as shown here. The cultures also produced varying amounts of PCA-methyl 
ester, which is not separated from PCA in this HPLC system but could be identified in the LC-MS 
analysis (data not shown). The more lipophilic, prenylated compound endophenazin A is 
predominantly found in cell extracts, not in the culture medium. 
Directly adjacent to the genes of the mevalonate pathway, a gene designated ppzP was identified 
(Fig. 1B). Its predicted gene product showed 44% identity to Fnq26, a prenyltransferase of the ABBA 
family that is involved in the biosynthesis of the meroterpenoid furanonaphtoquinone I (5). 
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LC-MS analysis showed that both 
S. anulatus and S. coelicolor(ppzOS04) 
also produced a small amount of 
endophenazine B as well as phenazine 
1-carboxylic acid methyl ester (data not 
shown). Both compounds were identified 
by LC-MS2 in comparison with authentic 
reference samples.  
As mentioned above, the screening 
of the cosmid library had identified a 
second cosmid, 11C7. Sequencing of 
the termini of its insert and comparison 
with the sequence obtained from 18A9 
showed that 11C7 lacked the gene ppzP 
(the putative prenyltransferase) and 744 
nucleotides of the mevalonate kinase 
gene but contained all other genes of 
the putative endophenazine cluster (see 
Fig. 1B). Cosmid 11C7 was expressed 
heterologously in S. coelicolor M512 
using the same method described 
above. The resulting strain S. 
coelicolor(ppzOS02) produced 
phenazine 1-carboxylic acid and its 
methyl ester but no prenylated 
phenazines (Fig. 2C). 
The results of the heterologous 
expression experiment with 18A9 prove 
that this cosmid contains all of the genes 
required for endophenazine 
biosynthesis. The experiment with 11C7 
indicates that ppzP may be responsible 
for the prenylation reaction in this 
pathway. However, 11C7 lacked not 
only ppzP but also the promoter of the 
putative operon of mevalonate 
biosynthesis genes (see Fig. 1B) as well 
as part of the mevalonate kinase gene. 
Therefore, the heterologous expression 
of 18A9 and 11C7 did not provide 
conclusive evidence for the function of 
ppzP. 
 
Inactivation of the Prenyltransferase 
Gene ppzP and Heterologous 
Expression of the Resulting 
Construct in S. coelicolor M512 
λ RED-mediated recombination was 
used to create an in-frame deletion of 
the gene ppzP within the integrative 
cosmid ppzOS04. For this purpose, the 
cassette pIJ773, containing the 
apramycin-resistant gene acc(3)IV and 
flanked with XbaI and SpeI restriction 
sites, was used to replace the coding 
sequence of the ppzP gene. 
Subsequently, the cassette was excised 
by XbaI and SpeI digestion and 
religation of the compatible overhangs, 
leaving only 6 bp as a “scar” sequence 
between the start and the stop codon of 
ppzP. The resulting integrative cosmid 
ppzOS09 was introduced into the 
genome of S. coelicolor M512 as 
described above. HPLC and LC-MS 
analysis of the cultures (Fig. 2D) showed 
phenazine 1-carboxylic acid and its 
methyl ester but no endophenazine A or 
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B. This strongly supported the 
hypothesis that ppzP is responsible for 
the prenylation reaction in 
endophenazine biosynthesis in the 
heterologous expression experiment. 
However, a polar effect of the deletion 
on the expression of the genes 
downstream of ppzP cannot be excluded 
with certainty. 
 
Overexpression and Purification of 
PpzP 
For the biochemical investigation of the 
putative prenyltransferase, the gene 
ppzP was cloned into a plasmid for 
expression as an N-terminally His-
tagged protein (see “Experimental 
Procedures”). The resulting construct 
was introduced into E. coli BL21 
(DE3)pLysS. Induction with isopropyl 1-
thio-β-d-galactopyranoside resulted in 
expression of a protein of ∼37 kDa, as 
determined by SDS-PAGE (Fig. S1), 
coinciding with the calculated molecular 
mass of 37.138 kDa. Ni2+ affinity 
chromatography resulted in a protein of 
∼90% purity. 30 mg of purified soluble 
PpzP were obtained from 2 liters of 
culture. This protein was used for the 
biochemical investigations described 
below. 
 
Identification of PpzP as 5,10-
Dihydrophenazine 1-Carboxylate 9-
Dimethylallyltransferase 
Phenazine 1-carboxylic acid has been 
suggested as the product of the core 
pathway of phenazine biosynthesis from 
which the differently substituted or 
dimerized phenazines are derived by 
various tailoring reactions (8). In 
different Pseudomonas strains, PCA is 
converted by the monooxygenase PhzO 
to 2-hydroxy-PCA, by the amide 
synthethase PhzH to phenazine 1-
carboxamide, and by the consecutive 
action of PhzM (methyltransferase) and 
PhzS (oxidoreductase) to pyocyanine (1-
hydroxy-5-N-methyl-phenazine). 
However, when we incubated PCA with 
PpzP and DMAPP under various 
conditions, we did not observe product 
formation in HPLC analysis. From 
chemical reasoning, the reduced form of 
PCA (i.e. dihydro-PCA) (Fig. 3A), 
appeared to be an attractive candidate 
for the prenylation substrate, since it is 
much more reactive than PCA for an 
electrophilic attack at C-9. Dihydro-PCA 
is presumed to be the direct biosynthetic 
precursor of PCA (8). We therefore 
generated dihydro-PCA by reduction of 
PCA with sodium dithionite (Fig. 3A). 
When dihydro-PCA was incubated with 
PpzP and DMAPP, the time-dependent 
formation of an enzymatic product was 
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readily observed by HPLC (Fig. 3B). 
Due to the very rapid oxidation of 
dihydro-PCA and its derivatives, they 
could not be quantified in the reduced 
form. After incubation, the reaction 
mixture was therefore oxidized with 
sodium persulfate (Na2S2O8), and 
substrate and product were analyzed in 
the oxidized form. The enzymatic 
product was thereafter identified as 
endophenazine A by LC-MS analysis 
showing the same retention time, UV 
spectrum, molecular ion (m/z = 293 in 
positive ionization), and fragmentation 
pattern in ESI-MS2 and ESI-MS3 as an 
authentic reference sample of 
endophenazine A. 
 
Biochemical Properties of PpzP 
In the enzymatic assay described under 
“Experimental Procedures,” the 
formation of endophenazine A showed a 
linear dependence on the amount of 
PpzP (up to 1 μg) and on the reaction 
time (up to 45 min). The reaction was 
strictly dependent on the presence of 
active PpzP, DMAPP, and dihydro-PCA. 
Maximal product formation was 
observed at pH 7.5, with half-maximal 
values at pH 9.5 and pH 5.0. In sharp 
contrast to the trans-prenyldiphosphate 
synthases like FPP synthase (30) and to 
the aromatic prenyltransferase NphB of 
naphterpin biosynthesis (3), the catalytic 
activity of PpzP was independent of the 
presence of Mg2+ or any other divalent 
metal ions. The addition of EDTA (10 
mM) even increased reaction velocity 
1.5-fold. Similarly, the addition of 500 
mM NaCl increased product formation 3-
fold, whereas the addition of 50 mM 
MgCl2 and 100 mM CaCl2 increased 
product formation ∼1.5-fold. Therefore, 
500 mM NaCl was routinely included in 
all assays (see “Experimental 
Procedures”). Although 10 mM Zn2+ had 
no effect on the reaction, the addition of 
10 mM FeSO4 completely abolished the 
formation of endophenazine A. 
PpzP was found to be specific for 
both DMAPP and dihydro-PCA. When 
geranyldiphosphate was used instead of 
DMAPP, no product formation was 
observed. Likewise, no prenylated 
products could be observed when PpzP 
was incubated with other phenazine 
substrates, such as phenazine, 
phenazine 1-carboxylic acid methyl 
ester, N-methyl-phenazine (as methyl 
sulfate salt), or pyocyanine (1-hydroxy-
5-N-methyl-phenazine). These 
phenazine substrates were reduced with 
dithionite to their dihydro analogs in the 
same way as described for PCA. Since 
N-methyl-phenazine and pyocyanine are 
compounds with quaternary nitrogens, 
these reaction mixtures were analyzed 
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directly without prior extraction with ethyl 
acetate. 
We also tested the aromatic 
substrates of previously examined ABBA 
prenyltransferases (i.e. 4-
hydroxyphenylpyruvate, flaviolin (2,5,7-
trihydroxynaphthoquinone), 1,3-
dihydroxynaphthalene, and 1,6-
dihydroxynaphthalene). Of these, only 
flaviolin was prenylated by PpzP in the 
presence of DMAPP. LC-MS confirmed 
that the product was a monoprenylated 
flaviolin derivative. However, the 
reaction velocity was only 0.5 % of that 
obtained with dihydro-PCA. A reaction 
mechanism of the C-prenylation of 
flaviolin under catalysis of Fnq26 was 
suggested by Haagen et al. (5). A similar 
mechanism may be expected for the 
prenylation of flaviolin by PpzP. 
However, the amount of the prenylated 
product was too low for a structural 
identification by NMR spectroscopy. 
Using a constant concentration of 
dihydro-PCA (0.8 mM) and varying 
concentrations of DMAPP, a typical 
hyperbolic curve of product formation 
over substrate concentration was 
obtained (Fig. 3C), indicating that the 
reaction followed Michaelis-Menten 
kinetics. Nonlinear regression analysis 
resulted in a Km value of 116 ± 9 μM and 
a Kcat of 0.435 ± 0.006 s-1. Using 
different concentrations of dihydro-PCA 
in the presence of 0.4 mM DMAPP, a 
sigmoidal dependence of product 
formation on substrate concentration 
was observed (Fig. 3D). The half-
maximal reaction velocity was obtained 
at ∼35 μM dihydro-PCA. 
Using this value (35 μM) as an 
estimate for the Km value for dihydro-
PCA, the catalytic efficiency (Kcat/Km) of 
PpzP was calculated as 12,400 M-1 s-1. 
This is significantly higher than the value 
of 7.7 M-1 s-1 reported for the conversion 
of the (artificial) substrate 1,3-
dihydroxynaphthalene by NphB (6) but is 
comparable with the value of 5280 M-1 
s-1 calculated for the prenylation of the 
(genuine) substrate 4-HPP by CloQ (4). 
We therefore suggested that dihydro-
PCA is the genuine substrate of PpzP. 
 
 
Investigation of Fnq28 from S. 
cinnamonensis DSM 1042 for 
Dihydro-PCA Dimethylallyltransferase 
Activity 
Our group recently reported a gene 
cluster of prenylated naphthoquinone 
and prenylated phenazine biosynthesis 
from S. cinnamonensis DSM 1042 (10). 
This strain produces, besides the 
prenylated naphthoquinone derivative 
furanonaphthoquinone I, the same 
prenylated phenazines as S. anulatus 
(10,12,20). The gene cluster from
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Figure 3: A, reaction scheme of the assay for dihydrophenazine 1-carboxylate dimethylallyltransferase 
activity. B, HPLC analysis of the dihydrophenazine 1-carboxylate prenyltransferase assay. C and D, 
product formation at different concentrations of DMAPP and dihydrophenazine 1-carboxylic acid. In C, 
dihydrophenazine 1-carboxylic acid was kept constant at 0.8 mM.In D, DMAPP was kept constant at 
0.4 mM. 
 
S. cinnamonensis contains genes 
assigned to furanonaphthoquinone I 
biosynthesis as well as a contiguous 
group of six genes (i.e. ephzBCDEGA) 
assigned to phenazine biosynthesis. By 
gene inactivation (10) and biochemical 
investigation (5), the prenyltransferase 
Fnq26 had been identified as the 
aromatic prenyltransferase of 
furanonaphthoquinone I biosynthesis. A 
second gene with similarity to ABBA 
prenyltransferases, designated as fnq28, 
was found immediately adjacent to the 
genes of the phenazine biosynthesis. 
Fnq28 shows 36% sequence identity 
with PpzP on the amino acid level. We 
tested whether Fnq28 also prenylates 
dihydro-PCA. For this purpose, Fnq28 
was expressed as an N-terminally His-
tagged protein, using the same method 
as employed for PpzP. Ni2+ affinity 
chromatography readily yielded a 
soluble protein of apparent homogeneity 
(data not shown). However, no 
prenylation of dihydro-PCA was 
observed with this protein, in clear 
contrast to the results with PpzP. 
Fnq26 has been shown previously to 
transfer a geranyl moiety to flaviolin 
(2,5,7-trihydroxynaphthoquinone) or to 
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the artificial substrate 1,3-
dihydroxynaphthalene. We now tested 
whether Fnq26 could also use dihydro-
PCA and either DMAPP or 
geranyldiphosphate as substrates. 
However, again no prenylation products 
were detected. These observations are 
consistent with the results from 
inactivation experiments, which had 
shown that endophenazine A is still 
formed in S. cinnamonensis after 
inactivation of both fnq26 and fnq28 
(10). Therefore, neither Fnq26 nor 
Fnq28 catalyzes the prenylation reaction 
of endophenazine biosynthesis in S. 
cinnamonensis. In this organism, the 
enzyme that functionally corresponds to 
PpzP of S. anulatus is yet to be 
identified. 
 
Discussion 
In this study, we have identified, for the 
first time, a prenyltransferase involved in 
the biosynthesis of prenylated 
phenazines. Sequence similarities and 
biochemical properties suggest that 
PpzP belongs to the recently discovered 
family of ABBA prenyltransferases (1). 
The present functional characterization 
of PpzP as 5,10-dihydrophenazine 1-
carboxylate 9-dimethylallyltransferase 
now extends the substrate range of this 
family, previously limited to phenolic 
compounds, to include also phenazine 
derivatives. 
At present, 13 genes with 
sequence similarity to ABBA 
prenyltransferases can be identified in 
the data base. A phylogenetic analysis 
of these genes (1) separates them into 
two clades. One of them comprises the 
4-hydroxyphenylpyruvate 3-
dimethylallyltransferases CloQ and 
NovQ from Streptomyces strains as well 
as four genes of unknown function from 
fungal genomes. The other clade 
comprises genes involved in the 
biosynthesis of prenylated 
naphthoquinones in different 
streptomycetes. A ClustalX analysis 
(data not shown) places PpzP into this 
second clade. Its closest ortholog is 
Fnq26, the prenyltransferase of 
furanonaphthoquinone I biosynthesis 
(5). 
The x-ray structural analysis of the 
ABBA prenyltransferase NphB (formerly 
designated as Orf2) had revealed a 
novel protein fold, characterized by a 
β/α-barrel with 10 antiparallel β-strands. 
A structural model of PpzP (Fig. S2), 
generated using NphB as template, 
suggests a close similarity of the three-
dimensional structure of the two 
proteins. The active center of NphB is 
localized within the spacious central 
cavity of the barrel, which has been 
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suggested to explain the promiscuity of 
this enzyme for different aromatic 
substrates (3). 
NphB requires the presence of 
Mg2+ for catalytic activity. X-ray 
crystallography has shown that the Mg2+ 
ion is coordinated by a single aspartate 
residue, by four water molecules, and by 
one of the oxygen atoms of the α-
phosphate group of the isoprenoid 
diphosphate (3). In contrast, PpzP does 
not require Mg2+ ions for its activity, and 
the same has been reported for the 
ABBA prenyltransferases CloQ (4), 
SCO7190 (3) and Fnq26 (5). Modeling 
studies suggested that positively 
charged residues (Lys54 in CloQ, Arg51 
in SCO7190, and Arg50 in Fnq26) may 
functionally substitute for Mg2+ in the 
binding of the α-phosphate group of the 
isoprenyl diphosphate (1,3). An 
alignment of PpzP with the enzymes 
named above (Fig. S3) shows that also 
PpzP contains an arginine residue 
(Arg49) in the respective position of the 
first β strand. This may explain the Mg2+ 
independence of the PpzP reaction. Like 
the other ABBA prenyltransferases, 
PpzP does not contain the DDXXD motif 
typical for trans-prenyldiphosphate 
synthases (1). 
In the biosynthesis of phenazines 
in different microorganisms, a common 
pathway leads to PCA, and this 
compound was believed to represent the 
branching point from which the 
pathways to differently substituted 
phenazines diverge (8). Our study now 
suggests that, at least for the prenylation 
of phenazines, the branching point is 
dihydro-PCA rather than PCA. This 
compound has been suggested (8) to be 
the product of the last enzyme-catalyzed 
step of the biosynthesis of the 
phenazine core, whereas its oxidation to 
PCA may occur non-enzymatically. 
Therefore, dihydro-PCA is likely to be 
available as substrate for PpzP in vivo. 
Our study reports the first complete 
gene cluster of phenazine biosynthesis 
from streptomycetes, after a previously 
identified cluster turned out to be 
incomplete (10). Natural phenazines 
have important biological activities, 
including antibacterial, antitumor, 
antioxidant, and testosterone 5α-
reductase-inhibiting activity (31). The 
present discovery of the endophenazine 
gene cluster from S. anulatus and the 
functional identification of PpzP as 
dihydro-PCA prenyltransferase may 
pave the way to the generation of new 
prenylated phenazines with improved 
biological activities by metabolic 
engineering and chemo-enzymatic 
synthesis. 
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Supplemental Data 
 
Fig. Fig. S1: Expression and purification of PpzP. Lane 1, molecular weight 
standards; lane 2, total protein before IPTG induction; lane 3, total protein after IPTG 
induction; lane 4, soluble protein after IPTG induction; lane 5, eluate from Ni-NTA-
agarose. The 12% polyacrylamide gel was stained with Coomassie Brilliant Blue R-
250. 
 
 
Fig. S2: Structural model of the dihydro-phenazine-1-carboxylate prenyltransferase 
PpzP, and experimentally determined structure of the prenyltransferase NphB. The 
unique fold of the ABBA prenyltransferases is characterized by a central barrel 
consisting of ten antiparallel β-sheets. The PpzP model was generated with the 
SWISS-MODEL program, using the PDB file 1zdyA as template. 
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Fig. S3: Structure based multiple sequence alignment of the ABBA 
prenyltransferases PpzP, Fnq26, CloQ, SCO7190 and NphB. The structure of NphB 
and the structure models of CloQ and SCO7190 are described by Kuzuyama et al. 
2005. The structure of PpzP and Fnq26 were generated with the SWISS-MODEL 
program using the PDP file 1zyA (NphB) as template. Arg49, suggested to coordinate 
the pyrophosphate group of the isoprenoid substrate, is indicated by an arrow. 
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Preface − About the Manuscript 
Adenylate-forming enzymes are important in the biosynthesis of aminocoumarin antibiotics. 
They are involved in the formation of the aminocoumarin ring in form of NRPS and later in 
the generation of an amide bond between the aminocoumarin ring and an acyl moiety. 
Especially for the generation of new derivatives, the substrate specificity of these amide 
synthetases is interesting. The following publication describes the identification and 
characterization of the adenylate forming enzymes from the rubradirin biosynthetic gene 
cluster involved in amide bond formation. Interestingly, the cluster contains three putative 
amide synthetases from which two showed activity and the third could be converted by site 
directed mutagenesis. One of the active ones represents a fusion protein which also 
comprises a NRPS module. This is the first example of a biosynthetic pathway to an 
aminocoumarin-containing natural product in which such a fusion of these catalytic activities 
are found, possible capable of channeling between the active sites without release into the 
medium. 
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- writing of the manuscript 
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- optimization of amide synthetase assays 
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My personal part for this manuscript involved performance of all initial experiments showing 
activity of RubC1 and Orf4. From these findings I and Prof. L. Heide designed further 
experiments to investigate the substrate specificity as well as to examine the kinetic 
constants. I planned and investigated the influence of mutations on the activity of RubF6. For 
this manuscript I wrote major text parts, generated figures and was in charge of the final 
version. 
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Abstract 
The biosynthesis of aminocoumarin antibiotics requires two acyladenylate-forming 
enzymes: one for the activation of L-tyrosine as a precursor of the aminocoumarin 
moiety and another for the linkage of an acyl moiety to the aminocoumarin moiety. 
Unexpectedly, the biosynthetic gene cluster of the aminocoumarin antibiotic 
rubradirin was found to contain three genes for putative acyladenylate-forming 
enzymes of aminocoumarin biosynthesis and conjugation. We expressed, purified, 
and investigated these three proteins. Orf4 (55 kDa) was shown to be an active 
aminocoumarin acyl ligase. RubF6 (56 kDa) was inactive, but could be converted into 
an active enzyme by site-directed mutagenesis. RubC1 (138 kDa) was shown to be a 
unique bifunctional enzyme, comprising an aminocoumarin acyl ligase, and tyrosine-
adenylation and peptidyl-carrier domains. This natural hybrid enzyme is unique 
among known proteins. A hypothesis is proposed as to how such an enzyme could 
offer a particularly effective machinery for aminocoumarin antibiotic biosynthesis.
 
Introduction 
The activation of acyl moieties by 
acyladenylate formation plays a central 
role in the biosynthesis of many 
antibiotics, especially nonribosomal 
peptides and polyketides (1). In the 
biosynthesis of the aminocoumarin 
antibiotic novobiocin (Scheme 1), a 
potent inhibitor of bacterial gyrase (2), 
two acyladenylate-forming enzymes are 
involved: NovH (600 aa), which activates 
tyrosine as a precursor of the 
aminocoumarin moiety (3), and NovL 
(527 aa), which links the aminocoumarin 
moiety to an acyl moiety by an amide 
bond (4). The biosynthetic gene clusters 
of the aminocoumarin antibiotics 
clorobiocin (5), coumermycin A1 (6) and 
simocyclinone (7,8) each contain an 
orthologue of novH and an orthologue of 
novL. The different substrate 
specificities of the aminocoumarin acyl 
ligases from these clusters - CloL, CouL, 
and SimL - have been utilized for the 
mutasynthetic and chemoenzymatic 
generation of new aminocoumarin 
antibiotics (9-12). 
In 2008, the biosynthetic gene 
cluster of the aminocoumarin antibiotic 
rubradirin was published (13). Rubradirin 
is an ansamycin antibiotic isolated from 
Streptomyces achromogenes var. 
rubradiris NRRL3061. It exhibits activity 
against many Gram-positive bacteria, 
including Staphylococcus aureus strains 
with multiple antibiotic resistance (14). 
Rubradirin inhibits translation at the 
Boll et al. • Adenylate-Forming Enzymes of Rubradirin Biosynthesis Chapter 6 
 
© 2011 The Authors. 
© 2011 Wiley-VCH Verlag GmbH& Co. KGaA, Weinheim 
Originally published in ChemBioChem. (2011), 12, 1105-14 
Page 60 
 
bacterial ribosomes (15), and the 
rubradirin aglycone has been shown to 
inhibit bacterial RNA polymerase by a 
different mechanism from those of 
ansamycins such as rifamycins, 
streptovaricins, and tolypomycins (16). 
Further biological effects of the 
rubradirin aglycone have also been 
described (17,18). 
Rubradirin is comprised of four 
distinct structural moieties (Scheme 1): 
the aminocoumarin moiety, the 
ansamacrolide moiety (termed 
rubransarol), the 3,4-
dihydroxydipicolinate (DHDP) moiety, 
and the deoxysugar D-rubranitrose 
(2,3,6-trideoxy-3-C-4-O-dimethyl-3-C-
nitro-D-xylo-hexose). The DHDP moiety 
is linked to the aminocoumarin moiety 
through an amide bond, the formation of 
which is expected to be catalyzed by an 
aminocoumarin acyl ligase. 
 
 
Scheme 1. Structures of the aminocoumarin antibiotics rubradirin, novobiocin, and 
simocyclinone D8. The aminocoumarin moieties are highlighted by boxes, and the amide 
bonds linking them to the different acyl moieties are accentuated in gray. 
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Unexpectedly, the biosynthetic gene 
cluster of rubradirin was found to contain 
not one but three putative genes for 
aminocoumarin acyl ligases with 
sequence similarity to NovL (13), that is, 
orf4, rubF6, and rubC1. The predicted 
gene product of rubC1 showed a unique 
chimeric structure, with similarity to 
NovL at its N terminus and similarity to 
NovH at its C terminus. This suggested 
that it might catalyze two different steps 
in aminocoumarin antibiotic 
biosynthesis, that is, activation of 
tyrosine as well as aminocoumarin acyl 
ligation. Such a chimeric enzyme has 
not been previously described. In this 
study, we expressed and purified the 
three putative adenylate-forming 
enzymes of the rubradirin biosynthetic 
gene cluster, that is, Orf4, RubF6, and 
RubC1, and investigated them 
biochemically. 
 
Results 
Sequence analysis of Orf4, RubF6 
and RubC1 
Figure 1 shows an alignment of the 
predicted proteins Orf4 (521 aa), RubF6 
(529 aa), and RubC1 (1317 aa) with 
NovL and NovH of novobiocin 
biosynthesis. Orf4, RubF6, and the N-
terminal 514 aa of RubC1 show 
sequence similarity to NovL (527 aa). At 
the amino-acid level, their respective 
identities to NovL are 34, 32, and 35 %. 
BLAST searches revealed that these 
proteins possess similarity to acyl-CoA 
synthetases. Correspondingly, they 
show conserved motifs of adenylate-
forming enzymes (Figure 1). Orf4 is 
extremely similar to RubF6 (88 % 
identity), but less so to the N-terminal 
part of RubC1 (49 % identity). 
RubC1 is much larger than Orf4 
and RubF6. While its N-terminal part 
shows similarity to NovL, its C-terminal 
600 aa show 46 % identity to the 
tyrosine-activating enzyme NovH (600 
aa; Figure 1). Using the NRPS-PKS 
software package (19) adenylation and 
peptidyl carrier protein (PCP) domains 
were identified in this portion of RubC1. 
The PCP domain contains a predicted 
attachment site for a 4′-
phosphopantetheinyl cofactor, marked in 
Figure 1. 
The specificity of adenylation 
domains for the activation of certain 
amino acids can often be predicted from 
the “specificity-conferring code”, which 
consists of approximately ten amino acid 
residues that line the substrate binding 
pocket of the respective enzyme (20). 
From this code, the NRPS-PKS software 
package (19) predicts that the 
adenylation domain in the C-terminal 
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Figure 1. Alignment of RubC1, Orf4, and RubF6 with the aminocoumarin acyl ligase NovL and 
the L-tyrosine-activating enzyme NovH. Ser1269, representing the 4′-phosphopantetheinyl 
attachment site of the PCP domain, is marked with an asterisk. The BoxI motifs of adenylate-
forming enzymes are highlighted with a frame. The (inactive) RubF6 shows poor conservation 
of this motif. The insertion of eight amino acids found in RubF6 is highlighted with a dotted 
frame. 
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part of RubC1 is specific for the 
activation of L-tyrosine; this is in 
accordance with the expected role of 
this part of RubC1 in the biosynthesis of 
the aminocoumarin moiety of rubradirin. 
The central part of the predicted 
RubC1 protein, approximately from 
amino acid 515 to 710 (Figure 1), shows 
low sequence similarity to other NRPS 
proteins in BLAST searches, with E 
values >0.05. No conserved domains 
are detected by BLAST searches in this 
part of RubC1. 
 
Expression and purification of Orf4, 
RubF6, and RubC1 
Orf4, RubF6, and RubC1 were 
expressed in E. coli in the form of N-
terminally His-tagged fusion proteins 
and purified by Ni2+-affinity 
chromatography (Figure 2). RubC1 was 
coexpressed with the nonspecific 4′-
phosphopantetheinyl transferase Sfp 
from Bacillus subtilis (21) to ensure 
phosphopantetheinylation of its PCP 
domain. The three proteins were 
obtained in yields of 26, 9, and 9 mg per 
liter of culture, respectively. The 
observed molecular weights in an SDS-
PAGE analysis corresponded to the 
calculated values for the His-tagged 
proteins, that is, 55, 58, and 140 kDa, 
respectively (Figure 2). 
 
Figure 2. Expression and purification of Orf4, 
RubF6, RubC1, and the C-terminal domain of 
RubC1 (termed RubC1b). Lane 1: total 
protein before IPTG induction, lane 2: total 
protein after IPTG induction, lane 3: insoluble 
protein after IPTG induction, lane 4: soluble 
protein after IPTG induction, lane 5: protein 
after Ni2+-affinity chromatography, lane 6: 
protein after size-exclusion gel chromato-
graphy, lane M: molecular mass standards. 
The calculated masses of the His-tagged 
proteins are 55.3 (Orf4), 57.9 (RubF6), 140.5 
(RubC1), and 66.8 kDa (RubC1b). The 12 % 
polyacrylamide gel was stained with CBB R-
250. 
 
Orf4 is a functional aminocoumarin 
acyl ligase 
Orf4 in the biosynthetic gene cluster of 
rubradirin shows clear sequence 
similarity to NovL (Figure 1). We first 
investigated the enzymatic activity of 
purified Orf4 with the same substrates 
as used previously in assays of NovL 
from novobiocin biosynthesis (4,22), 
namely 3-amino-4,7-dihydroxy-8-methyl-
coumarin (hereafter referred to as 
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methyl-aminocoumarin) as the amino 
substrate and 3-dimethylallyl-4-
hydroxybenzoic acid (3-DMA-4HBA) as 
the acyl substrate. In the presence of 
ATP and Mg2+, the enzyme-dependent 
formation of novobiocic acid, that is, the 
amide formed from these two substrates 
was readily detected by HPLC. The 
identity of the product was confirmed by 
comparing its HPLC and mass spectra 
to those of an authentic reference 
compound. 
3-DMA-4HBA is not an 
intermediate of rubradirin biosynthesis, 
but it has been found to be accepted as 
a non-natural substrate by other 
aminocoumarin acyl ligases, such as 
SimL of simocyclinone biosynthesis (23) 
and CouL of coumermycin A1 
biosynthesis (24). The natural acyl 
substrate of the aminocoumarin acyl 
ligase reaction in rubradirin is unknown. 
If the formation of the amide bond 
precedes the formation of the glycoside 
and the ester bonds in the rubradirin 
molecule (Scheme 1), the expected 
substrate would be 3,4-
dihydroxypyridine-2,6-dicarboxylic acid 
(3,4-dihydroxypipecolic acid). A 
commercially available analogue of this 
compound is 4-hydroxypyridine-2,6-
dicarboxylic acid (chelidamic acid in its 
enol form). However, Orf4 did not 
catalyze any detectable product 
formation with chelidamic acid or with 
several other pyridine-2,6-dicarboxylic 
acid derivatives (Table S1 in the 
Supporting Information). We tested Orf4 
with 24 different acyl substrates. Product 
formation was detected by HPLC and 
LC-MS with cinnamic acid, ferulic acid, 
and benzoic acid, as well as with 3-
DMA-4HBA, as mentioned above. In 
addition, HPLC analysis showed product 
formation with coumaric acid and 4-
hydroxybenzoic acid, but no unequivocal 
mass spectrometric data were obtained 
for the products formed from these 
compounds. The highest-yielding 
product formation was observed with 
cinnamic acid, as previously observed 
for the aminocoumarin acyl ligase SimL 
of simocyclinone biosynthesis (23). 
Therefore, cinnamic acid was used as 
the acyl substrate in further 
investigations of Orf4. 
Optimal product formation was 
measured at pH 7.5 in Tris-HCl buffer, 
with half maximal activities at pH 8.5 and 
6.8. The optimal ATP concentration was 
5 mM. At constant methyl-
aminocoumarin concentration (1.5 mM) 
with various concentrations of cinnamic 
acid, the Km value was determined to be 
2760 μM (Figure 3 A). This is 
considerably higher than the Km values 
observed for the natural substrates of 
NovL, CouL and SimL: 19, 26 and 20.4 
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μM, respectively (4,23,24). However, 
this was expected as cinnamic acid is 
not the natural substrate of the ligase 
reaction in rubradirin biosynthesis. Vmax 
was calculated as 92.3 pkat per mg 
protein, similar to the value of 90 pkat 
per mg protein measured for SimL with 
cinnamic acid (23). By keeping the 
cinnamic acid concentration constant at 
6 mM and varying the concentration of 
the aminocoumarin substrate, the Km 
value for methyl-aminocoumarin was 
determined to be 358 μM (Figure 3 A).  
Methyl-aminocoumarin is a 
structural moiety of novobiocin (22); 
however, the aminocoumarin moiety of 
rubradirin is unsubstituted in position 8. 
We therefore synthesized the 
corresponding 8-unsubstituted 
aminocoumarin according to a published 
procedure (25). The Km value of Orf4 for 
this substrate was found to be 73 μM, 
five times lower than for the non-natural 
methyl-aminocoumarin. Moreover, Vmax 
was higher for the 8-unsubstituted 
aminocoumarin than for the methyl-
aminocoumarin. In comparison, the Km 
values of NovL, CouL, and SimL for 
methyl-aminocoumarin have been 
previously determined to be 131, 44, 
and 20.5 μM, respectively (4,23,24). 
 
RubF6 is inactive but can be mutated 
to a functional aminocoumarin acyl 
ligase 
RubF6 is currently annotated in 
GenBank as a “putative aminocoumarin 
ligase”. This 529 aa protein shares 88 % 
identity with Orf4 (Figure 1). However, 
we found the purified RubF6 to be 
completely inactive in assays for 
aminocoumarin acyl ligase activity, using 
all 24 acyl substrates listed in Table S1. 
This is in clear contrast to the results 
obtained with Orf4. 
Closer inspection of the amino acid 
sequence showed two important 
differences between the inactive enzyme 
RubF6 and the active enzymes Orf4 and 
NovL. First, RubF6 has an insertion of 
eight amino acids in its sequence 
(AGASATGP, see Figure 1). Second, 
the sequence of RubF6 shows poor 
conservation of the BoxI motif, which is 
conserved in other adenylate-forming 
enzymes (Figure 1). Modeling of the 
structure of RubF6 with Salmonella 
enterica acetyl-CoA synthetase (PDB ID: 
2P2M) (26) as a template showed that 
the mutations in the BoxI motif in RubF6 
affect the loop that, in the S. enterica 
enzyme, is involved in ATP binding.  
One of the sequence differences in 
this loop is a lysine residue that has 
been proven to be involved in the 
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Figure 3. Determination of Km and Vmax values of A) Orf4 and B) RubC1 for acyl substrates and 
for two different aminocoumarin substrates in aminocoumarin acyl ligase assays. See text for 
further explanations. C) [32P]PPi-exchange assay of RubC1 and RubC1b with L-tyrosine and L-
phenylalanine. 
 
catalytic activity of adenylate-forming 
enzymes (27) but is missing from this 
loop in RubF6. 
We investigated whether the 
activity of RubF6 could be restored by 
modification of the sequence using site-
directed mutagenesis. Deletion of the 
eight-residue insertion in RubF6 did not 
result in detectable activity, neither did 
replacement of Asn184 in the BoxI motif 
with the amino acids Pro-Lys, found in 
the corresponding position of Orf4 and 
NovL. However, an active 
aminocoumarin acyl ligase was obtained 
when the mutation of Asn184 to Pro-Lys 
was combined with a mutation of amino 
acids 178–180 from Arg-Leu-Pro to Ser-
Gly-Ser (the sequence found in SimL 
and RubC1). The resulting RubF6 
mutant clearly showed activity in an 
assay with methyl-aminocoumarin and 
either cinnamic acid or 3-dimethylallyl-4-
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hydroxybenzoic acid. However, the 
catalytic activity was only 4.6 pkat per 
mg protein with cinnamic acid as the 
best-accepted substrate. This is only 5 
% of the activity observed for Orf4. 
 
RubC1 is a bifunctional enzyme with 
aminocoumarin acyl ligase activity 
and tyrosine-activating activity 
RubC1 is currently annotated in 
GenBank as a “putative acyl-coenzyme 
A ligase”. Sequence analysis had shown 
that its C-terminal part is similar to the 
tyrosine-activating enzyme NovH, while 
its N-terminal part is similar to the 
aminocoumarin acyl ligase NovL (Figure 
1). In the investigation described above, 
we showed that orf4 coded for a 
functional aminocoumarin acyl ligase. 
From the current hypothesis on 
rubradirin biosynthesis (13), only a 
single aminocoumarin acyl ligase is 
expected to be involved in this pathway. 
We therefore investigated whether the 
N-terminal part of RubC1 was a 
functional ligase or not. 
When purified RubC1 was 
incubated with methyl-aminocoumarin 
and 3-DMA-4HBA, the formation of 
novobiocic acid, was readily detected by 
HPLC. The reaction was dependent on 
the presence of ATP, Mg2+, and active 
enzyme. The identity of the product was 
confirmed by LC-MS by comparison with 
an authentic reference compound; the 
product was identical to those formed by 
NovL and Orf4 in the same assays. 
Of the other 23 acyl substrates 
shown in Table S1, RubC1 catalyzed 
product formation only with cinnamic 
acid, 4-coumaric acid, and ferulic acid. 
The products showed the expected 
molecular masses in LC-MS analysis, 
and were identical to those formed by 
Orf4. The highest product yield was 
observed with ferulic acid, and this 
substrate was used in the further 
characterization of the enzyme. 
Optimal product formation was 
observed with an ATP concentration of 6 
mM. Mg2+ (1 mM) strongly stimulated 
the activity. In Tris-HCl buffer, the 
optimal pH was 8.5, compared to 8.0 for 
NovL and 7.5 for Orf4. Half-maximal 
reaction velocity was observed at pH 
values of 7.4 and 9.5. Addition of NaCl 
reduced the activity, with nearly 
complete inhibition at concentrations of 
500 mM and higher. 
The apparent Km value for the non-
natural substrate ferulic acid was 
determined as 1.7 mM (Figure 3 B), 
similar to the value of 2.7 mM observed 
for Orf4 with its preferred acyl substrate, 
cinnamic acid. Concentrations of ferulic 
acid exceeding 7.5 mM resulted in 
inhibition, and therefore only the data 
from concentrations up to 7.5 mM were 
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included in the nonlinear regression 
analysis for Km determination. The 
apparent Km value for methyl-
aminocoumarin was 358 μM, similar to 
the value of 250 μM observed for Orf4. 
Vmax was calculated as 98.7 pkat per mg 
protein. 92.3 pkat per mg protein had 
been calculated for Orf4, but since the 
molecular weight of RubC1 is 2.5 times 
higher than that of Orf4, the turnover 
number of RubC1 is higher than that of 
Orf4. Similarly, as observed for Orf4, the 
Km value of RubC1 for the 8-
unsubstituted aminocoumarin (205 μM) 
was lower than that of the 8-methylated 
compound (Figure 3 B). However, in the 
case of RubC1, this difference was less 
pronounced than for Orf4, and Vmax was 
lower than observed for methyl-
aminocoumarin. L-Tyrosine and L-
phenylalanine were tested as alternative 
amino substrates of RubC1, but no 
amide formation was observed in the 
HPLC analysis. 
Sequence analysis of RubC1 had 
shown an adenylation and a PCP 
domain at the C terminus, similar to 
NovH, which activates tyrosine as a 
precursor of the aminocoumarin moiety 
of novobiocin (3). To confirm the 
enzymatic activity of this C-terminal part 
of RubC1, we tested its ability to 
catalyze the adenylation of tyrosine 
using the ATP-[32P]PPi exchange assay. 
This is a well-established assay 
commonly used for the investigation of 
aminoacyl-adenylating enzymes (28,29). 
It measures the incorporation of 
radioactive pyrophosphate into ATP. We 
used the same reaction conditions as 
employed previously for the investigation 
of NovH (3). 
Upon incubation of RubC1 with L-
tyrosine, ATP, Mg2+, and [32P]PPi, 
radioactive ATP was formed. The 
reaction depended on the presence of 
active enzyme and each of the named 
assay components. As expected, RubC1 
activity was specific for the amino acid: 
activity with L-phenylalanine was six 
times lower than with L-tyrosine, and no 
activity was observed with L-tryptophan 
(Figure 4 A). 
The Km and Vmax values of RubC1 
for L-tyrosine were determined as 155 
μM and 6.31 nkat per mg protein. For 
NovH, the corresponding values were 
reported as 1390 μM and 4.0 nkat per 
mg protein, measured under identical 
conditions. For L-phenylalanine, RubC1 
showed Km and Vmax values of
Chapter 6 Boll et al. • Adenylate-Forming Enzymes of Rubradirin Biosynthesis
 
 
Page 69 
© 2011 The Authors. 
© 2011 Wiley-VCH Verlag GmbH& Co. KGaA, Weinheim 
Originally published in ChemBioChem. (2011), 12, 1105-14
 
 
Figure 4. Relative adenylation activity of RubC1 and RubC1b towards different acids. Activity 
was assessed by ATP-[32P]PPi-exchange assays. 
 
approximately 4600 μM and 1.7 
nkat per mg protein, thus confirming that 
the affinity of this enzyme for tyrosine 
was much higher than for phenylalanine. 
 
Auto-aminoacylation of RubC1 with 
[14C]Tyr 
The ability of holo-RubC1 to ligate the 
activated L-Tyr onto the thiol of the 4′-
phosphopantetheinyl arm on the PCP 
domain was assayed by using L-[U-
14C]tyrosine as a substrate. As depicted 
in Figure 5, SDS-PAGE and 
autoradiographic analysis clearly 
showed ATP-dependent covalent 
loading of L-Tyr onto RubC1. This 
indicated that the PCP domain in 
RubC1, at the C-terminal side of the 
adenylation domain, is functional. 
 
Tyrosine-adenylating activity, but not 
ferulic acid-adenylating activity is 
localized in the C-terminal part of 
RubC1 
We subsequently tried to separately 
express the N-terminal part of RubC1, 
which is similar to the aminocoumarin 
acyl ligase NovL, and the C-terminal part 
of RubC1, which is similar to the L-
tyrosine-activating enzyme NovH, as N-
terminally His8-tagged proteins in E. coli. 
The C-terminal part, comprising amino 
acids 689–1317 of RubC1 and hereafter 
termed RubC1b, was readily obtained as 
soluble protein in good yield (41 mg per 
L culture). In contrast, expression of the 
N-terminal part, comprising amino acids 
1–521, resulted only in insoluble protein, 
despite repeated attempts under 
different culture conditions. We also tried 
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Figure 5. Demonstration of the ATP-dependent auto-aminoacylation of RubC1 with L-[U-
14C]tyrosine. A) CBB-stained 10 % SDS-PAGE gel of two reaction mixtures. Lane M: molecular 
weight markers, lane −ATP: control reaction without ATP; lane Rxn: complete reaction. B) 
Autoradiogram of the same gel. 
 
to express a slightly larger N-
terminal portion of RubC1, comprising 
aa 1-570, but again obtained only 
insoluble protein. Further biochemical 
experiments were therefore carried out 
only with the C-terminal fragment, 
RubC1b. 
The [32P]PPi-exchange assay 
readily confirmed the L-tyrosine-
activating activity of RubC1b, with a 
similar substrate preference for L-
tyrosine in comparison to L-
phenylalanine and L-tryptophan as 
observed for RubC1 holoenzyme (Figure 
4 B). The Km value for L-tyrosine was 
determined as 59 μM (Figure 3 C). 
However, the activity of RubC1b was 
lower than that of the holoenzyme, by 
approximately two orders of magnitude 
(Figure 3). From these results we 
conclude that, in the absence of the N 
terminus, the structure of the protein is 
not optimal. 
Ferulic acid is adenylated by the 
RubC1 holoenzyme with approximately 
7 % of the reaction velocity observed for 
tyrosine. In contrast, no adenylation of 
ferulic acid was observed with RubC1b 
(detection limit: 0.1 % of the velocity 
obtained with tyrosine). This indicated 
that the ferulic acid adenylation activity 
was located in the N-terminal rather than 
the C-terminal part of RubC1, in 
agreement with the hypothesis that the 
aminocoumarin feruloyl ligase reaction 
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described above is catalyzed by the N-
terminal part of the molecule. 
The fact that RubC1 shows higher 
activity for the adenylation of L-tyrosine 
than of ferulic acid (Figure 4 A) was 
expected, as L-tyrosine is a natural 
substrate of this enzyme, while ferulic 
acid is not. 
 
Discussion 
All naturally occurring aminocoumarin 
antibiotics contain an aminocoumarin 
moiety that is linked to an acyl moiety by 
an amide bond. The biosynthesis of 
these antibiotics requires at least two 
acyladenylate-forming enzymes. First, 
an enzyme for the adenylation of L-
tyrosine and its subsequent attachment 
to the 4′-phosphopantetheinyl cofactor of 
a peptidyl carrier protein (PCP). The 
prototype of such a tyrosyl-activating 
enzyme is NovH (3), consisting of an 
adenylation and a PCP domain. Second, 
the biosynthesis requires an enzyme for 
the adenylation of an acyl moiety and its 
subsequent transfer to the amino group 
of the aminocoumarin moiety. The 
prototype of such an aminocoumarin 
acyl ligase is NovL (4). NovL is similar in 
sequence to the acyl-CoA ligases (30). 
In contrast to nonribosomal peptide 
synthases, NovL contains neither a PCP 
nor a condensation domain, and it does 
not form a covalent bond with its 
substrate (4). 
The biosynthetic gene cluster of 
rubradirin (13) contains two genes with 
similarity to novL - orf4 and rubF6 - and 
additionally a unique hybrid gene, 
rubC1, which represents a fusion of 
orthologues of novL and novH with a 
600 bp linker region. In this study, we 
have shown that Orf4 is an active 
aminocoumarin acyl ligase with 
biochemical properties similar to those 
of SimL of simocyclinone biosynthesis 
(23,31). However, RubF6, which shares 
88 % identity with Orf4 on the amino 
acid level, was inactive. Site-directed 
mutagenesis of the active site allowed 
us to convert RubF6 into an active 
aminocoumarin acyl ligase. The high 
sequence identity of rubF6 to orf4 
suggests that these genes might have 
resulted from a gene-duplication event. 
One of the copies might then have 
mutated to an inactive form. 
The natural acyl substrate of the 
aminocoumarin acyl ligase reaction in 
rubradirin biosynthesis is unknown. It is 
possible that the entire acyl moiety - 
consisting of rubransorol, the 
deoxynitrosugar, and dihydroxy-
pipecolinic acid - is assembled before its 
transfer to the aminocoumarin moiety, 
similar to the biosynthetic reaction 
sequence of simocyclinone (23). 
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However, this complex acyl moiety of 
rubradirin has not been isolated or 
synthesized, and therefore could not be 
tested as substrate in this study. 
The substrate specificity of RubC1 
in the aminocoumarin acyl ligase assay 
was similar to that of Orf4 (Table S1). 
Our data indicate that both Orf4 and the 
N-terminal domain of RubC1 may be 
able to act as aminocoumarin acyl 
ligases in rubradirin biosynthesis. 
RubC1 is a bifunctional enzyme. In 
addition to its aminocoumarin acyl ligase 
activity, RubC1 catalyzes the 
adenylation of tyrosine and its covalent 
attachment to a PCP domain. Both 
sequence analysis and biochemical 
investigation suggested that the latter 
functions are localized to the C-terminal 
part of RubC1, which is therefore 
expected to have identical function to 
that of NovH in novobiocin biosynthesis 
(Scheme 1) (2,3). 
BLAST searches revealed many 
homologues to either the N- or the C-
terminal part of RubC1, but not a single 
homologue with significant similarity 
over the full-length protein. The hybrid 
enzyme RubC1 is different from any 
NRPS or NRPS-PKS hybrid described 
previously (32,33). 
The biosynthetic gene cluster of 
simocyclinone contains a gene for the 
aminocoumarin acyl ligase SimL and, 28 
bp downstream thereof, a gene for the 
tyrosine-activating enzyme SimH (Figure 
6). In contrast to NovH (600 aa), SimH 
(997 aa) shows an N-terminal extension 
of approximately 400 aa. The function of 
this extension, if any, is unknown. If the 
genes simL and simH were fused to a 
single coding sequence, the resulting 
gene would code for a protein with a 
very similar domain structure to RubC1. 
However, the 400 aa N-terminal 
extension of SimL does not show 
sequence similarity to the 200 aa linker 
region in RubC1, thus excluding a direct 
evolutionary relationship of rubC1 to 
simL or simH. 
The biochemical functions that 
RubC1 can fulfill in the biosynthesis of 
rubradirin are depicted in Scheme 2, in 
analogy to the established function of 
the five enzymes NovHIJKL of 
novobiocin biosynthesis, which are 
transcribed as a single operon (Figure 6) 
(34). The genes rubC1, rubC2, and 
rubC3 in the rubradirin biosynthetic gene 
cluster resemble this operon. rubC2 and 
rubC3 are orthologues of novI and novJ, 
respectively. RubC3 alone might carry 
out the same reaction as NovJ/NovK, as 
all three enzymes belong to the FabG 
family of 3-ketoacyl-(acyl-carrier protein) 
reductases (35). RubC1 might adenylate
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Figure 6. Organization of genes for adenylate-forming enzymes of aminocoumarin biosynthesis 
in the biosynthetic gene clusters of novobiocin (nov), simocyclinone (sim), and rubradirin 
(rub). The rubradirin gene cluster spans 106 kb, and the genes orf4, rubF6, and rubC1 are 
found at different loci within this cluster. 
 
tyrosine and link it to the 4′-
phosphopantetheinyl cofactor of its PCP 
domain. Subsequent β-hydroxylation of 
the tyrosyl moiety by RubC2 and 
oxidation by RubC3 would be carried out 
on the covalent tyrosyl-S-RubC1 
complex (Scheme 2). Upon cyclization, 
the aminocoumarin moiety would be 
released from its covalent bond to 
RubC1 resulting in the substrate for the 
aminocoumarin acyl ligase (36). 
However, rather than being released into 
the cytoplasm, this moiety could be 
directly channeled to the N-terminal 
domain of RubC1, where its amino 
group would be acylated under catalysis 
of the aminocoumarin acyl ligase 
domain of RubC1 (Scheme 2). By this 
channeling mechanism, the unique 
bifunctional enzyme RubC1 could offer 
an efficient machinery for 
aminocoumarin antibiotic biosynthesis. 
 
Experimental Section 
Chemicals and radiochemicals 
Tetrasodium [32P]pyrophosphate (3.38 
TBq mmol−1) was obtained from Perkin–
Elmer, L-[U-14C]tyrosine (14.65 
GBq mmol−1) from Moravek 
Biochemicals and Radiochemicals. 3-
Amino-4,7-dihydroxy-8-methyl-coumarin 
and novobiocic acid were kindly 
provided by Pharmacia & Upjohn, Inc. 
(Kalamazoo, MI). 3-Dimethylallyl-4-
hydroxybenzoic acid was obtained by 
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Scheme 2. Hypothetical role of RubC1 in the biosynthesis and the acylation of the 
aminocoumarin moiety of rubradirin. aaL=aminocoumarin acyl ligase domain; A=tyrosine 
adenylation domain; PCP=peptidyl carrier domain. 
 
hydrolysis of novobiocin, as 
described previously (22). Acyl 
substrates for Orf4 and RubC1 were 
purchased from Sigma–Aldrich, Fluka, 
Lancaster and Merck. 
 
Cloning of the genes orf4, rubF6, and 
rubC1 
The genes orf4, rubF6, and rubC1 of the 
rubradirin cluster were amplified from a 
cosmid library of S. achromogenes var. 
rubradiris NRRL 306113 by polymerase 
chain reaction. Primers orf4_f_NdeI (5′-
GGG AAT TCC ATA TGA GTA CCA 
CGC ATG TGC ATT ATG-3′) 
orf4_r_XhoI (5′-GAG ATG GTT CTC 
GAG TCA GGC CTG GGG GGC G-3′), 
rubC1_f_NcoI (5′-CAT GCC ATG GCA 
TGC GGG GGC ATG ATC ACT ACA-3′) 
and rubC1_r_EcoRI (5′-CCG GAA TTC 
TCA TCG GCG GCC TCC ACG-3′) 
were used to amplify orf4 and rubC1. 
Primers orf4_r_XhoI and rubF6_r_XhoI 
(5′-GAT CCA TCC CTC GAG CTA GGC 
CTG GGG GGC G-3′) were used to 
amplify rubF6. rubC1b was amplified 
with primers rubC1b_f_NcoI (5′-CAT 
GCC ATG GGC GCC TGC TCG GGG 
CAT TTC G-3′) and rubC1_r_EcoRI (see 
above). The introduced NdeI, XhoI, NcoI 
and EcoRI restriction sites of each 
primer are highlighted in bold. The 
amplified products were purified by gel 
electrophoresis, digested with the 
corresponding restriction enzymes, and 
ligated into pET28a for expression of 
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Orf4 and RubF6 as N-terminally His6-
tagged constructs, and into pHis8 (37) 
for expression of RubC1 and RubC1b N-
terminally His8-tagged constructs. The 
resulting plasmids pBB02 and pBB04 
were transformed into E. coli Rosetta2 
(DE3), while pBB05 and pBB11 were 
transformed into E. coli BL21(DE3) with 
pSU20_sfp, a plasmid containing the 
gene for the Sfp phosphopantetheinyl 
transferase from Bacillus subtilis (21) for 
protein overexpression of holo-RubC1 
and holo-RubC1b. 
Site-directed mutagenesis of 
RubF6 was carried out by PCR 
amplification of the template pBB04 
using the QuickChange Site Directed 
Mutagenesis Kit (Stratagene). Reactions 
were performed according to the 
manufacturer’s instructions with primers 
rubF6_N184PK_f (5′-AGG CTG CCG 
AGC GGA CGG cca AAa GGC CTC 
TGC TGG ACC TTC-3′), 
rubF6_RL178SG_f (5′-GGT GAT CAC 
CCA GAC CAG tgg GCC GAG CGG 
ACG GAA CGG-3′) and their reverse 
complements. The base changes are 
indicated by small letters. The PCR 
program consisted of an initial 
denaturation at 94 °C for 2 min followed 
by 18 cycles of 94 °C for 10 s, 55 °C for 
30 s, and 68 °C for 9 min. For the 
deletion of the insertion sequence of 
rubF6, the Phusion Site-Directed 
Mutagenesis Kit (New England Biolabs) 
was used according to the 
manufacturer’s instructions with the 
primers rubF6_∆207–215_f (5′P-CGT 
GGA GGG CAG GGA CGG-3′) and 
rubF6_∆207–215_f (5′P-ACG ACC CTC 
CTG ATC ACC GC-3′). The template 
DNA was digested with 10 units of DpnI 
for 1 h at 37 °C before transformation. 
The correct DNA sequences of the 
entire genes were confirmed by 
sequencing. 
 
Purification of His-tagged proteins 
An overnight culture in Luria-Bertani 
medium (35 mL, 50 μg mL−1 kanamycin, 
25 μg mL−1 chloramphenicol) of cells 
harboring the respective expression 
plasmid were used to inoculate terrific 
broth (38) (1 L, 50 μg mL−1 kanamycin, 
25 μg mL−1 chloramphenicol). The cells 
were grown at 37 °C to an OD600 of 0.6, 
cooled to 20 °C, induced with isopropyl-
β-D-thiogalactopyranoside (IPTG; 0.4 
mM), and allowed to grow for an 
additional 14 h at 20 °C. The cells from 
each culture were harvested by 
centrifugation (15 min at 4800 x g) and 
resuspended in buffer A (25 mL per 10 g 
cells, 50 mM Tris-HCl, pH 8.0, 0.5 M 
NaCl, 20 mM imidazole, 5 mM β-
mercaptoethanol, 10 % glycerol). 1 % 
Tween 20 and lysozyme (0.5 mg mL−1) 
were added, resuspended cells were 
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broken by a Branson sonifier, and the 
cell debris was removed by 
centrifugation (45 min at 35 000 x g). 
The supernatant was applied to a 
nickel–nitrilotriacetic acid–agarose resin 
column (GE Healthcare) according to 
the manufacturer's instructions by using 
a linear gradient of 0–60 % imidazole 
(250 mM, in 50 mM Tris-HCl, pH 8.0, 
500 mM NaCl, 10 % glycerol, 10 mM β-
mercaptoethanol) over 60 min for 
elution. Fractions containing the protein 
were pooled and further purified on a 
HiLoad 26/60 Superdex 200 column 
(Amersham Pharmacia Biotech) that had 
been equilibrated with Tris-HCl (20 mM, 
pH 8.0), NaCl (150 mM), and 
dithiothreitol (2 mM), concentrated by 
using an Amicon Ultra 10 000 MWCO 
centrifugal filter (Millipore), flash frozen 
in liquid nitrogen, and stored at −80 °C. 
Concentrations of the purified RubC1 
and RubC1b were measured 
spectrophotometrically at 280 nm by 
using the calculated extinction 
coefficients of 0.820, 0.884, 0.735, and 
0.712 g L−1 for Orf4, RubF6, RubC1, and 
RubC1b, respectively. His-tagged 
constructs were used without further 
modifications. 
 
ATP-[32P]PPi-exchange assays with 
RubC1 and RubC1b 
ATP-[32P]PPi-exchange assays 
(100 μL) contained Tris-HCl (75 mM, pH 
8.0), MgCl2 (5 mM), tris(2-
carboxyethyl)phosphine hydrochloride 
(TCEP; 5 mM), ATP (2 mM), amino acid 
substrate (1.5 mM), RubC1 (0.5 μM), 
and [32P]pyrophosphate (1 mM, Perkin–
Elmer). The reactions were initiated by 
the addition of RubC1 or RubC1b, 
allowed to proceed for 5 min at 30 °C, 
and then quenched with a suspension of 
activated charcoal (500 μL, 1.6 %, w/v) 
in quenching buffer (4.5 %, w/v 
tetrasodium pyrophosphate and 3.5 % 
perchloric acid in water). The charcoal 
was pelleted by centrifugation, washed 
with quenching buffer, resuspended in 
water (0.5 mL), and added to scintillation 
liquid (9 mL). The radioactivity was 
quantified in a scintillation counter. Data 
reported are means of two independent 
reactions. RubC1 (4 μM) was used for 
incubations with L-phenylalanine as the 
substrate, and the reactions were 
allowed to continue for 10 min at 30 °C. 
Nonlinear regression was performed 
with Graph Pad Prism 5.0 (GraphPad 
Software Inc., La Jolla, USA). 
 
Amide synthetase assays 
Assay mixtures (100 μL) contained Tris-
HCl (95 mM, pH 7.5 for Orf4 and pH 8.5 
for RubC1), 3-amino-4,7-dihydroxy-8-
methyl-coumarin (0.5 mM in DMSO), the 
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respective carboxylic acid substrate (6 
mM), ATP (6 mM), and MgCl2 (1 mM). 
Reactions were initiated with Orf4 or 
RubC1 and carried out for 30 min at 
30 °C. The reactions were terminated by 
addition of an equal volume of methanol 
at 4 °C. After incubation at -20 °C for 20 
min, the mixtures were centrifuged to 
remove precipitated protein (5 min, 
15 700 g). The supernatant was 
analyzed by RP-HPLC using a 
Multosphere RP18–5 column (250×4 
mm, 5 μm; C+S Chromatographie 
Service, Düren, Germany), with a linear 
gradient of 50-100 % solvent B (99 % 
CH3OH, 1 % HCOOH) in solvent A (99 
% H2O, 1 % HCOOH) over 28 min, flow 
rate 1 mL min−1. UV detection was 
carried out at 330 nm. The identity of the 
products was confirmed by LC-MS. 
 
Auto-aminoacylation of RubC1 
The incubation mixture (100 μL) 
included Tris-HCl (95 mM, pH 8.0), 
MgCl2 (5 mM), L-[U-14C]tyrosine (0.1 
mM, Moravek Biochemicals and 
Radiochemicals), TCEP (5 mM), ATP (2 
mM), and RubC1 (50 μM). The reaction 
was allowed to proceed for 30 min at 30 
°C, and 10 μL of the mixture were used 
for electrophoresis on 10 % SDS-PAGE. 
A control reaction was carried out in 
parallel in which ATP was omitted. For 
visualization, the gel was stained with 
Coomassie brilliant blue solution. The 
dried gel was exposed to a 
photostimulable phosphor plate for 72 h 
before development with a phosphor 
imager. 
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Supplemental Data 
Table S1. Aminocoumarin acyl ligase activities of Orf4, RubF6 and RubC1 
with different acyl substrates (pkat mg-1 protein) 
Substrates RubC1 Orf4 RubF6 
cinnamic acid 10.4  92.3  < 0.2 
ferulic acid 98.7  9.9  < 0.2 
p-coumaric acid 2.9  9.3 < 0.2 
caffeic acid < 0.2 < 0.2 < 0.2  
3-dimethylallyl-4-hydroxybenzoic acid 6.3  15.8  < 0.2  
benzoic acid < 0.2  0.5  < 0.2 
4-hydroxybenzoic acid < 0.2  0.9  < 0.2 
vanillic acid < 0.2 < 0.2 < 0.2  
2,3-dihydroxybenzoic acid < 0.2 < 0.2 < 0.2 
3,4-dihydroxybenzoic acid < 0.2 < 0.2 < 0.2 
3,5-dimethyl-4-hydroxybenzoic acid < 0.2 < 0.2 < 0.2 
3-bromo-4-hydroxybenzoic acid < 0.2 < 0.2  < 0.2  
3,5-dibromo-4-hydroxybenzoic acid < 0.2 < 0.2 < 0.2 
4-aminobenzoic acid < 0.2  < 0.2 < 0.2 
4-amino-3-hydroxybenzoic acid < 0.2 < 0.2 < 0.2 
4-hydroxy-3-propylbenzoic acid < 0.2 < 0.2  < 0.2  
(3,4-dihydroxyphenyl)acetic acid < 0.2  < 0.2  < 0.2  
(3,4-dihydroxyphenyl)hydroxyacetic acid < 0.2 < 0.2 < 0.2 
3-(3,4-dihydroxyphenyl)propanoic acid < 0.2 < 0.2 < 0.2 
3,5-dimethylpyrrolidine-2,4-dicarboxylic acid < 0.2 < 0.2 < 0.2 
chelidamic acid < 0.2 < 0.2 < 0.2 
pyridine-2,6-dicarboxylic acid < 0.2 < 0.2 < 0.2 
2,6-dimethyl-3,5-pyridinedicarboxylic acid < 0.2  < 0.2  < 0.2  
6-methylpyridine-2,3-dicarboxylic acid < 0.2 < 0.2 < 0.2 
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Preface − About the Manuscript 
MbtH-like proteins reside in many bacterial gene clusters of non-ribosomal formed secondary 
metabolites. The function of these small proteins remained a mystery for a long time. 
Recently, several biochemical studies shed light on their function. The following publication 
describes the role of MbtH-like proteins in aminocoumarin and vancomycin biosynthesis. 
MbtH-like proteins were found to bind to the L-tyrosine adenylating enzymes and thereby 
greatly stimulate their activity. The study contributes to understand the diversity of these 
proteins, their promiscuity in interacting with alternate adenylating domains, and the 
stoichiometry of the interaction. Additionally, a single point mutation near the active center 
resulted in MbtH-independent activity of a formerly MbtH-dependent adenylating enzyme. 
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Summary 
MbtH-like proteins consist of approximately 70 amino acids and are encoded in the 
biosynthetic gene clusters of non-ribosomally formed peptides and other secondary 
metabolites derived from amino acids. Recently, several MbtH-like proteins have 
been shown to be required for the adenylation of amino acid in non-ribosomal 
peptide synthesis. We now investigated the role of MbtH-like proteins in the 
biosynthesis of the aminocoumarin antibiotics novobiocin, clorobiocin and 
simocyclinone D8 and of the glycopeptide antibiotic vancomycin. The tyrosine-
adenylating enzymes CloH, SimH and Pcza361.18, involved in the biosynthesis of 
clorobiocin, simocyclinone D8 and vancomycin, respectively, required the presence 
of MbtH-like proteins in a 1:1 molar ratio, forming heterotetrameric complexes. In 
contrast, NovH involved in novobiocin biosynthesis showed activity in the absence of 
MbtH-like proteins. Comparison of the active centers of CloH and NovH showed only 
one amino acid to be different, i.e. L383 versus M383. Mutation of this amino acid in 
CloH (L383M) indeed led to MbtH-independent adenylation activity. All investigated 
tyrosine-adenylating enzymes exhibited remarkable promiscuity for MbtH-like 
proteins from different pathways and organisms. YbdZ, the MbtH-like protein from the 
expression host E. coli, was found to bind to adenylating enzymes during expression 
and to influence their biochemical properties markedly. Therefore, the use of ybdZ-
deficient expression hosts is important in biochemical studies of adenylating 
enzymes. 
 
Introduction 
The adenylation of amino acids is a key 
step in the biosynthesis of many 
antibiotics (e.g. vancomycin, 
daptomycin), immunosuppressants (e.g. 
cyclosporine A), siderophores (e.g. 
enterobactin, mycobactin) and other 
bioactive molecules (1). The activated 
amino acids can be assembled to 
peptides by non-ribosomal peptide 
synthases (NRPSs), leading e.g. to the 
backbone of vancomycin, or can serve 
as precursors of non-peptidic antibiotics 
like novobiocin, clorobiocin and 
simocyclinone D8 (Fig. 1). Approximately 
half of the biosynthetic gene clusters for 
non-ribosomally formed peptides, as well 
as the gene clusters for clorobiocin and 
simocyclinone D8, contain so-called 
mbtH-like genes. These small genes are 
named after mbtH contained in the gene 
cluster for the siderophore mycobactin in 
Mycobacterium tuberculosis which codes 
for a 71 aa protein. The function of 
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mbtH-like genes has remained enigmatic 
for many years. First proof that these 
genes are essential for secondary 
metabolite production was provided by a 
gene inactivation and complementation 
study of our group in clorobiocin 
biosynthesis (2) and by a similar study in 
the biosynthesis of coelichelin and 
calcium-dependent antibiotic (3). In vivo 
investigations were complicated by the 
fact that many bacterial genomes 
contain several mbtH-like genes which 
can functionally replace each other. The 
importance of a specific mbtH-like gene 
for the biosynthesis of a secondary 
metabolite can only be assessed after all 
other mbtH-like genes in the genome 
have been inactivated (2,3). However, in 
vivo studies could not define the precise 
physiological function of the mbtH-like 
genes, e.g. in catalysis, regulation, 
transport or protein-protein interactions. 
The three-dimensional structures of two 
MbtH-like proteins have been 
experimentally determined (4,5), but 
again this did not allow to recognize their 
function.  
 
Figure 1: Structures of the aminocoumarin antibiotics novobiocin, clorobiocin and simocyclinone D8 
and of the glycopeptide antibiotic vancomycin. Parts derived from L-tyrosine are drawn bold. 
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The first biochemical evidence for 
the function of MbtH-like proteins in non-
ribosomal peptide biosynthesis has 
recently been provided in two rapid 
reports by Felnagle et al. (6) and Zhang 
et al. (7). Additional data were presented 
as part of a study on glidobactin 
biosynthesis (8). These reports showed 
that MbtH-like proteins interact with 
adenylating enzymes which are part of 
NRPSs. In vitro, the adenylating activity 
of these enzymes was strongly 
stimulated by addition of MbtH-like 
proteins. Out of the five adenylation 
domains which activate the different 
amino acids required for capreomycin 
biosynthesis, three were dependent on 
the presence of the MbtH-like protein 
CmnN, while the two others were not. 
The reason for this difference is 
unknown (6). The heterologous 
expression of adenylating enzymes in E. 
coli was found to be difficult or even 
impossible unless the respective MbtH-
like protein was co-expressed 
simultaneously (6-8). From these data, 
Imker et al. (8) concluded that MbtH-like 
proteins act as activators, chaperones or 
both in NRPS assembly line. MbtH-like 
proteins form complexes with the 
adenylating enzymes, but the 
stoichiometry of these complexes has 
remained unclear. After purification of 
such complexes, the molar ratio of 
adenylating enzyme to MbtH-like protein 
was reported as 1:0.42 by Felnagle et al. 
(6), and as 1:1.7 by Imker et al. (8). If the 
adenylating enzyme CmnO and the 
MbtH-like protein CmnN were purified 
separately, a mixture of both in a 1:1 
molar ratio showed only low activity. 10-
fold higher activity was observed when 
the MbtH-like protein was added in a 16- 
to 32-fold molar excess (6). Therefore, 
the composition of the complex of MbtH-
like proteins with adenylating enzymes is 
yet obscure.  
As pointed out in a recent review 
on the occurrence and functions of MbtH 
proteins (9), the requirement of many 
adenylating enzymes for MbtH-like 
proteins implicates that the correct use 
of mbtH-like genes is a crucial factor for 
the success of combinatorial 
biosynthesis experiments. Our group is 
working extensively on the combinatorial 
biosynthesis of new aminocoumarin 
antibiotics (10,11). We were therefore 
interested to investigate the role of 
mbtH-like genes in the formation of 
these antibiotics. The biosynthesis of 
aminocoumarins involves the 
adenylation of L-tyrosine, followed by its 
attachment to a peptidyl carrier protein 
(PCP) domain and its ß-hydroxylation by 
a cytochrome P450 enzyme (Fig. 2A) 
(12,13). The same reaction sequence is 
part of the biosynthesis of vancomycin 
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and related glycopeptide antibiotics (14). 
In contrast to non-ribosomal peptide 
biosynthesis, however, the resulting ß-
hydroxytyrosine (ß-OH-Tyr) is not 
transferred by a condensation domain to 
a peptide backbone. Rather, in the 
biosynthesis of vancomycin and the 
related balhimycin, ß-OH-Tyr is liberated 
from the PCP domain by a thioesterase 
and subsequently activated by another 
specific adenylation domain of the 
vancomycin or balhimycin NRPS (Fig. 
2A) (15). 
In aminocoumarin biosynthesis, ß-
OH-Tyr is oxidized and cyclized to 4,7-
dihydroxy-3-aminocoumarin, which is 
liberated from the PCP domain and 
 
 
Figure 2: A) Adenylation and β-hydroxylation of tyrosine in the biosynthesis of aminocoumarin 
antibiotics and vancomycin. B) Genes for the formation of 4,7-dihydroxy-3-aminocoumarin and β-
hydroxytyrosine in the biosynthetic gene clusters of novobiocin (nov), clorobiocin (clo), simocyclinone 
(sim), and vancomycin (pcza). 
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subsequently connected to an acyl 
moiety via an amide bond (Fig. 2A). In 
contrast to non-ribosomal peptide 
biosynthesis, formation of this amide 
bond does not involve the intermediary 
attachment of the acyl moiety to a PCP 
domain (12,16). 
The biosynthetic gene clusters of 
vancomycin, clorobiocin and 
simocyclinone contain the mbtH-like 
genes orf1van, cloY and simY, 
respectively. In the vancomycin cluster, 
the gene orf1van is located 14 kb 
upstream from the genes coding for the 
enzymes for tyrosine adenylation (i.e. 
Pcza361.18), ß-hydroxylation and 
thioester cleavage (Fig. 2B). In the 
simocyclinone and clorobiocin clusters, 
the mbtH-like genes simY and cloY are 
located directly adjacent to the genes 
responsible for tyrosine adenylation and 
ß-hydroxylation, i.e. to simH/simI and 
cloH/cloI, albeit on different sides (Fig. 
2B). Surprisingly, the novobiocin cluster 
does not contain an mbtH-like gene, 
despite otherwise exactly identical 
organization of the genes for 
aminocoumarin biosynthesis (Fig. 2B). In 
vivo studies have suggested that the 
formation of the aminocoumarin moiety 
of clorobiocin requires an intact mbtH-
like gene, but the identical reaction 
sequence in novobiocin biosynthesis 
does not (2). Given the fact that the 
tyrosine-adenylating enzyme NovH has 
the same size (600 aa) as CloH, and 
both proteins share 83 % identity in their 
amino acid sequence (Fig. S1, 
Supplemental Data), this difference in 
the requirement for MbtH-like proteins is 
puzzling. We decided to express the 
tyrosine-adenylating enzymes NovH, 
CloH, SimH and Pzca361.18 as well as 
the cognate MbtH-like proteins, and to 
biochemically investigate these enzymes 
and the complexes formed by them. 
 
Experimental Procedures 
Chemicals and radiochemicals. 
Tetrasodium [32P]pyrophosphate (3.38 
TBq mmol-1) was obtained from Perkin 
Elmer. L-tyrosine was purchased from 
Merck. 
 
Cloning of the genes novH, cloH 
simH, cloY, simY, cdaX, pcza361.18 
and orf1van 
The genes novH, cloH, simH, cloY and 
simY were amplified from cosmids 
containing the respective clusters (17-
19) by polymerase chain reaction. The 
gene cdaX was amplified from 
chromosomal DNA of S. coelicolor 
M512. Primers novH_f_NdeI (5’-GGG 
AAT TCC ATA TGT TCA ACA CAC 
GTG CGA AC-3’) novH_r_XhoI (5’-GCC 
CTC GAG TCA CTC CTC CAG GGT 
CGC TA-3’), cloH_f_NdeI (5’-GGG AAT 
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TCC ATA TGT TAA ACA CGG GTC 
TGA ACA A-3’), cloH_r_XhoI (5’- GCC 
CTC GAG TCA CTC CCC GAG GGT 
CG -3’) simH_f_NdeI (5’-GGG AAT TCC 
ATA TGG CCA TGC CAT CCG GCA-
3’), simH_r_XhoI (5’-GCC CTC GAG 
TCA CTT CAC GGC CGT TGT GG -3’), 
cloY_f_NdeI (5’-GGG AAT TCC ATA 
TGG CGA CGA ACC CGT TCG A-3’), 
cloY_r_XhoI (5’-GCC CTC GAG CTA 
CTC GCC ACC CAT CGC-3’), 
simY_f_NdeI (5’-GGG AAT TCC ATA 
TGG CCA ACC CGT TTG ACG A-3’), 
simY_r_XhoI (5’-GCC CTC GAG TCA 
GCT GGG GTC CGT CG-3’), 
cdaX_f_NdeI (5’-GGG AAT TCC ATA 
TGA CCA ATC CGT TCG AAG ACG-3’), 
cdaX_r_XhoI (5’- GCC CTC GAG TCA 
GTT GCC GGT GCT CAT CG-3’), were 
used to amplify novH, cloH, simH, cloY, 
simY and cdaX. The introduced NdeI 
and XhoI restriction sites of each primer 
are highlighted in bold. The amplified 
products were purified by gel 
electrophoresis, digested with 
corresponding restriction enzymes and 
ligated into pET28a for expression as N-
terminally His6-tagged fusion proteins. 
The nucleotide sequences of 
pcza361.18 and orf1van were optimized 
for expression in E. coli and synthesized 
commercially by Mr. Gene (Regensburg, 
Germany). The two genes were excised 
from their vectors with NdeI and XhoI 
and ligated into vector pET28a using the 
same restriction sites. For coexpression 
of CloH and CloY, both genes were 
ligated in the dual expression vector 
pETDUET1 (Novagene). The cloH gene 
was amplified with primers introducing a 
thrombin restriction site at the N-
terminus: cloH_f_BamHI (5‘-CGG GAT 
CCC CTG GTC CCG CGT GGT TCC 
TTA AAC ACG GGT CTG AAC AAG 
GC-3‘); cloH_r_NotI (5’-A TAA GAA TGC 
GGC CGC TCA CTC CCC GAG GGT 
CG-3‘). Restriction sites of each primer 
are highlighted in bold, the thrombin 
cleavage site is underlined. cloY was 
amplified with the same primers as 
before and ligated via the restriction sites 
NdeI and XhoI, resulting in an untagged 
protein. The correct DNA sequences of 
the entire genes were confirmed by 
sequencing. The resulting plasmids 
pBB28 (simY), pBB32 (cdaX), pBB34 
(orf1van) and pBB37 (cloY) were 
transformed into E. coli Rosetta2 (DE3). 
pBB25 (simH), pBB26 (cloH), pBB35 
(cloH and cloY), pBB43 (pcza361.18) 
and pBB44 (novH) were transformed into 
E. coli BL21(DE3) either with or without 
carrying an ybdZ deletion, and carrying 
pSU20_sfp, a plasmid containing the 
gene for the Sfp phosphopantetheinyl 
transferase from Bacillus subtilis for 
expression of the holo-enzymes (20). 
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Generation of ∆ybdZ E. coli 
BL21(DE3) strain 
The E. coli BL21(DE3) ∆ybdZ mutant 
was generated in BL21(DE3)/pIJ790 
using Red/ET-mediated recombination 
(21). An apramycin resistance cassette 
[acc(3)IV] was amplified from plasmid 
pIJ773 (21). The primers used for PCR 
were as follows: ybdZ_f: (5‘-CCT CTG 
GCA ACC ACT TTT CCA TGA CAG 
GAG TTG AAT ATG TGT AGG CTG 
GAG CTG CTT C-3‘) and ybdZ_r (5‘-
TGC CGG GCT GTG CGG CGA CCA 
AAG GTA AAT GCT GGC TCA ATT 
CCG GGG ATC CGT CGA CC-3‘ ). Italic 
letters represent 39 nucleotides 
homologous to the regions up- and 
downstream of ybdZ, allowing Red/ET-
mediated recombination. The amplicon 
was electroporated into a 
BL21(DE3)/pIJ790 strain after induction 
of the λ RED recombination system by 
arabinose. Strains containing the 
ybdZ::acc(3)IV mutation were selected 
on LB apramycin (100 μg ml-1) at 37 °C 
leading to loss of the temperature-
sensitive plasmid pIJ790. The genotype 
of the resulting mutants was confirmed 
by PCR with chromosomal DNA. 
 
Site directed mutagenesis of CloH 
Site directed mutagenesis of CloH was 
carried out by PCR amplification of the 
template cloH_pGEMT using the 
QuickChange Site Directed Mutagenesis 
Kit (Stratagene). Reactions were 
performed according to the 
manufacturer’s instructions with primers 
of cloH_L383M_f (5’- CCC GAC TTG 
ACC GCG CAG aTG TTC GTG GCC 
AAC CCG T -3’), and the reverse 
complement. The base changes are 
indicated by small letters. The PCR 
program consisted of an initial 
denaturation at 94 °C for 2 min followed 
by 18 cycles of 94 °C for 10 s, 55 °C for 
30 s, and 68 °C for 6 min. The template 
DNA was digested with 10 units of DpnI 
for 1 h at 37 °C before transformation. 
The correct DNA sequence of the entire 
gene was confirmed by sequencing, and 
the DNA fragment was cloned in pET28a 
via NdeI and XhoI. 
 
Purification of His-tagged Proteins 
35 ml of an overnight culture in Luria-
Bertani medium (50 μg ml−1 kanamycin, 
25 μg ml−1 chloramphenicol) of cells 
harboring the respective expression 
plasmid were used to inoculate 1 liter of 
terrific broth (50 μg ml−1 kanamycin, 25 
μg ml−1 chloramphenicol). The cells were 
grown at 37 °C to an OD600 of 0.6, 
cooled to 20 °C, induced with 0.4 mM of 
IPTG and allowed to grow for an 
additional 14 h at 20 °C. The cells from 
each culture were harvested by 
centrifugation (15 min at 4800×g) and 
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resuspended in 25 ml of buffer A (50 mM 
Tris–HCl pH 8.0, 0.5 M NaCl, 20 mM 
imidazole, 5 mM β-mercaptoethanol, 10 
% glycerol) per 10 g cells. 1% Tween 20 
and 0.5 mg/ml lysozyme were added, 
resuspended cells were broken by a 
Branson sonifier and the cell debris was 
removed by centrifugation (45 min at 
35,000×g). The supernatant was applied 
to a nickel-nitrilotriacetic acid-agarose 
resin column (GE Healthcare) according 
to the manufacturer's instructions, using 
a linear gradient of 0–60% 250 mM 
imidazole (in 50 mM Tris-HCl pH 8.0, 
500 mM NaCl, 10% glycerol, 10 mM β-
mercaptoethanol) in 60 min for elution. 
Fractions containing the protein were 
pooled and further purified with a HiLoad 
26/60 Superdex 200 column (Amersham 
Pharmacia Biotech) that had been 
equilibrated with 20 mM Tris-HCl pH 8.0, 
150 mM NaCl and 2 mM dithiothreitol, 
concentrated using an Amicon Ultra 
10,000 MWCO centrifugal filter 
(Millipore) and stored at -80 °C. 
Concentrations of the purified proteins 
were measured spectrophotometrically 
at 280 nm using the calculated extinction 
coefficients. The N-terminal His-tags of 
the MbtH-like proteins were removed by 
incubation with 0.4 units thrombin 
(Sigma) per milligram of MbtH protein for 
8 h at 4 °C before gel filtration. The 
tyrosine-adenylating enzymes were used 
without further modifications. The MbtH-
like proteins were obtained in the 
following amounts per liter culture CloY 
6.9mg, SimY 27 mg, CdaX 23.8 mg and 
Orf1van 30.2 mg. From the ∆ybdZ 
expression hosts, the tyrosine-
adenylating enzymes were obtained in 
the following amounts: NovH 38.6 mg, 
CloH 2.83 mg, SimH 9.4 mg, 
Pcza361.18 10.3 mg. From the ybdZ+ 
expression hosts, the yields were: NovH 
64 mg, CloH 11.3 mg, Pcza361.18 21.6 
mg. The protein yield for the 
coexpression of CloH and CloY was 4.8 
mg per liter culture using the ∆ybdZ 
expression host. The mutant protein 
CloHL383M yielded 1.46 mg per 100 ml 
culture. 
 
ATP-[32P]PPi Exchange Assays 
ATP-[32P]PPi exchange assays (100 μl) 
contained 95 mM Tris-HCl (pH 8.0), 5 
mM MgCl2, 5 mM tris(2-
carboxyethyl)phosphine hydrochloride 
(TCEP), 2 mM ATP, 1.5 mM L-tyrosine, 
1 μM of the respective tyrosine-
activating enzyme, 1.2 µM of the 
respective MbtH-like protein (unless 
other amounts are indicated) and 1 mM 
[32P]pyrophosphate (Perkin Elmer). The 
reactions were initiated by the addition of 
the tyrosine-activating enzyme and 
allowed to proceed for 5 min at 30 °C, 
and then quenched with 500 μl of a 
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suspension of activated charcoal (1.6% 
w/v) in quenching buffer (4.5% (w/v) 
tetrasodium pyrophosphate and 3.5% 
perchloric acid in water). The charcoal 
was pelleted by centrifugation, washed 
with quenching buffer, resuspended in 
0.5 ml of water and added to 9 ml 
scintillation liquid. Radioactivity was 
quantified in a scintillation counter. Data 
reported are means of two independent 
reactions. Activity was expressed in katal 
(kat) (22). For investigation of enzyme 
kinetics, nonlinear regression was 
performed with Graph Pad Prism 5.0 
(GraphPad Software Inc., La Jolla, 
USA). 
 
Analytical gel filtration 
Analytical gel filtration was performed 
using a Superdex 200, 10/300 GL 
column (GE Healthcare) with a 24 ml 
bed resin and a buffer system of 20 mM 
Tris-HCl, pH 8.0, and 150 mM NaCl. A 
standard curve plotting the log of 
molecular weight standards versus the 
calculated Kav was generated using the 
following protein standards: ribonuclease 
A, chymotrypsinogen, ovalbulmin, 
albumin, aldolase, catalase and ferritin 
(GE Healthcare). This standard curve 
was used to calculate the observed 
molecular weight of SimH and 
SimH/SimY complexes. 
 
Results 
Expression and purification of 
tyrosine adenylating enzymes and 
MbtH-like proteins 
The tyrosine-adenylating enzymes 
NovH, CloH, SimH and Pcza361.18 as 
well as the MbtH-like proteins CloY, 
SimY and Orf1van were expressed in E. 
coli in form of N-terminally His-tagged 
proteins and purified by Ni2+ affinity 
chromatography, followed by gel 
chromatography. The MbtH-like proteins 
were subjected to thrombin cleavage in 
order to remove the His-tag before gel 
chromatography (see Experimental 
Procedures). 
The genome of E. coli contains an 
mbtH-like gene, ybdZ, in the gene 
cluster for the siderophore enterobactin. 
Felnagle et al. (6) have shown that 
purified YbdZ can activate adenylating 
enzymes of different NRPSs, albeit with 
low efficiency. In order to exclude the 
possibility that YbdZ would copurify with 
the expressed adenylating enzymes and 
interfere with subsequent investigations, 
we deleted the ybdZ gene from the E. 
coli expression host, utilizing the same 
Red/ET-mediated recombination 
strategy as described in a previous study 
of our group (11). The expression and 
purification of the adenylating enzymes 
was carried out both using the 
unmodified and using the ∆ybdZ 
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expression host. Notably, the yields of 
the adenylating enzymes from the ∆ybdZ 
expression strain were 2-4 times lower 
than from the unmodified strain (see 
Experimental Procedures). Using the 
∆ybdZ strain, most of the expressed 
CloH was insoluble, leading to a low 
yield of soluble protein (2.8 mg per liter 
culture). This is in accordance with 
previously reported difficulties in 
expressing adenylating enzymes without 
the corresponding MbtH-like proteins (6-
8). In contrast, NovH was readily 
obtained in a yield of 38.6 mg per liter 
culture. Fig. S2 (Supplemental Data) 
shows an SDS-PAGE analysis of the 
adenylating enzymes purified from the 
∆ybdZ strain, and of the purified MbtH-
like proteins. 
We also purified the MbtH-like 
protein CdaX encoded in the gene 
cluster for the calcium-dependent 
antibiotic (CDA) of Streptomyces 
coelicolor. Our previous in vivo studies 
had shown that cdaX can functionally 
replace cloY in the biosynthesis of the 
aminocoumarin moiety of clorobiocin (2). 
The gene products of the MbtH-like 
proteins Orf1van (AAL90876.1), CloY 
(AAN65223), SimY (AAG34186) and 
CdaX (CAB38589) comprise 70, 71, 69 
and 71 amino acids, respectively. As 
shown in a phylogenetic analysis of 
MbtH-like proteins by Zhang et al. (7), 
CdaX and CloY are situated in close 
proximity in one branch of the 
phylogenetic tree, and Orf1van and 
SimY in another branch. Sequence 
identity among these proteins is around 
60 %. 
The tyrosine-adenylating enzymes 
Pcza361.18 (CAA11773) and CloH 
(AAN65224) comprise 580 and 600 
amino acids, respectively, and show 43 
% identity to each other. In contrast, the 
gene product of simH (AAL15600) 
comprises 997 amino acids. Like 
Pcza361.18 and CloH, SimH contains an 
adenylation and a PCP domain, and 
these domains show 56 % sequence 
identity to CloH. However, SimH carries 
additional 400 amino acids at is N-
terminus. This domain shows moderate 
similarity to the condensation domains of 
NRPSs, but no function can be assigned 
to it in simocyclinone biosynthesis. As 
mentioned above, NovH (AAF67501) 
has exactly the same size as CloH, and 
these two proteins share 83 % sequence 
identity (Fig. S1, Supplemental Data). 
 
The tyrosine-activating enzymes 
CloH, SimH and Pcza361.18 are 
dependent on MbtH-like proteins 
The purified proteins were investigated 
for their tyrosine-adenylating activity 
using the well-established 
pyrophosphate exchange assay, 
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following the procedure described in a 
previous study on NovH (13). When 
assayed alone, CloH, SimH and 
Pcza361.18 showed a very low activity 
(Fig. 3). Upon addition of the respective 
MbtH-like protein, however, adenylating 
activity was readily detectable. A control 
with MbtH-like proteins alone showed no 
activity. 
The results depicted in Fig. 3 
were obtained with proteins expressed in 
the ∆ybdZ E. coli strain. If CloH and 
Pcza361.18 were expressed in an E. coli 
strain with intact ybdZ, results were 
markedly different: in this case, tyrosine-
adenylating activity of CloH and 
Pcza361.18 alone could clearly be 
detected, amounting to 20-30 % of the 
activity measured after addition of the 
respective MbtH-like protein. This 
suggests that YbdZ of E. coli had been 
copurified with the heterologously 
expressed adenylating enzymes. In 
contrast, SimH purified from strains with 
intact ybdZ gene did not show more 
activity than protein purified from a 
∆ybdZ strain. 
 
The tyrosine-activating enzyme NovH 
is active in the absence of MbtH-like 
proteins 
In clear contrast to CloH, SimH and 
Pcza361.18, NovH purified from the 
∆ybdZ strain showed activity in the 
absence of an MbtH-like protein (Fig. 3). 
This MbtH-independent activity is in 
agreement with our previous in vivo 
study which showed that biosynthesis of 
novobiocin, but not of clorobiocin, can be 
readily observed in strains which 
completely lack mbtH-like genes (2). 
However, activity of NovH was only 
moderate, and was stimulated markedly 
upon addition of CloY (Fig. 3). In view of 
the fact that the novobiocin cluster does 
not contain an mbtH-like gene, this result 
was unexpected. 
 
Figure 3: Activities of L-tyrosine-adenylating 
enzymes in the absence and presence of MbtH-
like proteins. The MbtH-like proteins were added 
in a 1.2-fold molar excess over the tyrosine-
adenylating enzymes. Data represents the mean 
value of two independent reactions. The value 
for CloH is the mean of six independent 
reactions. 
 
Enzyme kinetics of the adenylation of 
L-tyrosine 
We determined the Km and kcat values for 
the adenylation of tyrosine catalyzed by 
either NovH alone or by a mixture of 
NovH and CloY, using the 
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pyrophosphate exchange assay. The Km 
value for L-tyrosine was nearly identical 
in both cases, but addition of CloY 
clearly increased the observed turnover 
number (Table 1). We noticed, however, 
that the observed Km value (275 µM) 
was more than five times lower than the 
Km value of 1390 µM determined for the 
same enzyme in an earlier study by 
Chen and Walsh (13). In that study, 
NovH had been expressed in an E. coli 
strain with intact ybdZ. This prompted us 
to repeat the investigation of NovH, this 
time using a protein expressed in an 
ybdZ+ strain. Indeed, that protein 
showed a Km value of 1278 µM for L-
tyrosine, very similar to the value 
previously determined by Chen and 
Walsh (13). The turnover number of the 
enzyme from the ybdZ+ strain (0.12 s-1) 
was 1.6 times higher than that from the 
∆ybdZ strain. It appears therefore likely 
that YbdZ had been copurified with 
NovH, similar as we observed for CloH 
and Pcza361.18. These data show that 
MbtH-like proteins influence both the 
turnover number of the tyrosine-
adenylating enzyme and their Km value 
for the amino acid. Although the 
copurified YbdZ increased the turnover 
number observed for NovH, it actually 
decreased the catalytic efficiency (kcat 
Km-1) due to the increased Km (Table 1). 
As mentioned above, CloH, SimH 
and Pcza361.18 showed only very low 
activity in the absence of MbtH. 
Therefore, no kinetic investigations could 
be performed with these proteins alone. 
However, when the cognate MbtH-like 
protein was added, kinetic data could be 
readily obtained. The Km values for L-tyr 
ranged from 85 to 186 µM and the kcat 
values from 0.50 to 1.91 s-1 (Table 1). 
For all investigated proteins, the 
dependency of the reaction velocity on 
L-tyrosine concentration is depicted in 
Fig. S3 (Supplemental Data). 
Table 1: Kinetic parameters of tyrosine-adenylating enzymes in the presence of MbtH-like proteins. 
Unless indicated otherwise, proteins were expressed in an E. coli strain in which the mbtH-like gene 
ybdZ has been deleted. Tyrosine-adenylating enzymes and MbtH-like proteins were mixed in a molar 
ratio 1:1.2. The reaction velocities determined at different tyrosine concentrations and the statistical 
variation of the parameters are depicted in Fig. S3 (Supplemental Data). 
 
 Km for L-tyr [µM] kcat [s-1] kcat Km-1 [s-1 M-1] 
NovH alone 275 0.079 290 
NovH alone, expressed 
      in ybdZ+ E. coli 1278 0.120 94 
NovH + CloY 277 0.438 1580 
CloH and CloY 186 0.497 2670 
SimH and SimY 164 1.01 6180 
Pcza361.18 and Orf1van 85 1.91 22200 
 
Boll et al. • Role of MbtH-like Proteins in the Adenylation of Tyrosine Chapter 7 
 
© 2011 The Authors. 
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. 
Originally published in The Journal of Biological Chemistry. (2011), 286, Publication ahead of print  
Page 94 
 
Stoichiometry of the SimH/SimY and 
CloH/CloY complexes 
Previous investigations (6-8) had 
suggested that adenylating enzymes and 
MbtH-like proteins form complexes, but 
the stoichiometry of these complexes 
had remained unclear (see Introduction). 
We now investigated the adenylating 
activity of SimH and CloH in the 
presence of different amounts of SimY 
and CloY, respectively. As depicted in 
Fig. 4, activity steadily increased with 
increasing amounts of MbtH-like protein 
until a molar ratio of 1:1 was reached. 
Addition of further amounts of MbtH-like 
protein did not lead to a further increase 
of activity, suggesting that the active 
complex contains both proteins in a 
molar ratio of 1:1. 
We subsequently carried out an 
analytical gel chromatography of SimH 
alone and of a SimH/SimY mixture. 
Calibration of the column with reference 
proteins allowed to determine the 
apparent molecular weight of the eluted 
proteins. SimH (theoretical molecular 
mass 107.3 kDa) aggregated in aqueous 
solution, showing a dominant peak at 
approximately 650 kDa (Fig. 5A). In 
contrast, the mixture of SimH and SimY 
showed a dominant peak at 208 kDa. 
This is in reasonable agreement with the 
calculated molecular weight of a 
heterotetrameric (SimH)2(SimY)2 
complex (229 kDa). We isolated this 
peak from the analytical column. SDS-
PAGE analysis readily showed both 
SimH and SimY protein as components 
of the complex (Fig. 5B). Similar results 
were obtained for CloH and CloY (Fig. 
S4, Supplemental Data). However, CloH 
alone formed dimers in solution, and 
therefore in analytical gel 
chromatography the difference between 
CloH alone and the CloH/CloY complex 
was small. 
 
 
Figure 4: L-tyrosine-adenylating activity of CloH and SimH in the presence of different amounts of the 
MbtH-like proteins CloY and SimY. 
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A         B 
   
Figure 5: A) Molecular weight determination of the SimH/SimY complex by analytical gel 
chromatography. B) SDS-PAGE of the peak eluting at 208 kDa. 
 
Coexpression of CloH and CloY 
Felnagle et al. (6) had reported that the 
adenylating enzymes CmnO and VioO 
showed moderate activity upon addition 
of the MbtH-like proteins CmnN and 
VioN. However, much higher activity 
could be obtained when CmnO or VioO 
(as N-terminally his-tagged proteins) 
were simultaneously expressed with 
CmnN or VioN (as untagged proteins), 
followed by copurification of the proteins 
in form of the resulting complexes. From 
the supplemental data of the publication 
of Felnagle et al. (6), it can be estimated 
that the activities of the coexpressed 
CmnO/CmnN and VioO/VioN were 10-
fold and 75-fold higher than the activities 
of complexes obtained by mixing of 
separately purified proteins. The reason 
for this observation is unknown. 
We decided to coexpress N-
terminally his-tagged CloH and untagged 
CloY using a pETDUET1 vector 
(Novagene). As expected, purification by 
Ni2+ affinity chromatography and by gel 
chromatography resulted in an active 
tyrosine-adenylating enzyme, indicating 
that CloH and CloY had formed a 
complex resulting in their copurification. 
However, in contrast to the results of 
Felnagle et al. (6), this complex was not 
more active, but 50 % less active than a 
mixture of separately purified CloH and 
CloY proteins. Addition of CloY to the 
complex increased the activity but again 
not to a value higher than observed for a 
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mixture of separately purified CloH and 
CloY. This indicates that some CloY may 
have been lost from the complex during 
purification, causing a loss of activity 
which could be restored by external 
addition of CloY. 
 
Stimulation of tyrosine-adenylating 
enzymes by cognate and noncognate 
MbtH-like proteins 
Each of the four tyrosine-adenylating 
enzymes NovH, CloH, SimH and 
Pcza361.18 was assayed with each of 
the MbtH-like proteins CloY, CdaX, SimY 
and Orf1van in a molar ratio of 1:1.2. As 
shown in Fig. 6, all enzymes were 
stimulated by all MbtH-like proteins. In 
each case, addition of CloY resulted in 
the highest activity. Therefore, SimH and 
Pcza361.18 did not show preference for 
their cognate MbtH-like proteins, i.e. 
SimY and Orf1van, respectively. 
 
Generation of an L383M mutant of 
CloH 
NovH showed tyrosine-activating activity 
in the absence of an MbtH-like protein. 
This is in contrast to CloH, which shows 
83 % sequence identity to NovH. A 
sequence alignment (Fig. S1, 
Supplemental Data) shows no 
conspicuous differences between both 
proteins. No experimentally determined 
structure is available for NovH or CloH. 
We therefore modeled their structure 
after PheA (PDB ID: 1AMU). PheA is the 
phenylalanine-adenylating domain of the 
GrsA protein, which is part of the NRPS 
responsible for gramicidin S biosynthesis 
(23). PheA (556 aa) shows 37 and 39 % 
identity to the adenylation domains of 
NovH and CloH, respectively. A 
comparison of the structural models of 
NovH and CloH showed that all amino 
acids which are different between the 
two proteins are located distantly from 
the active center, with one single 
exception: in position 383, which is close 
to the active center, NovH contains a 
methionine and CloH a leucine residue. 
PheA contains a lysine residue in the 
corresponding position (K396). Modeling 
suggested that the size and nature of the 
residue in this position may influence the 
orientation of the side chains of a 
conserved tyrosine residue (Y397 in 
NovH/CloH, Y409 in PheA) and a 
neighboring glutamate residue (E316 in 
NovH/CloH and E327 in PheA). These 
residues assist in the binding of the Mg2+ 
ion in the active center. The positions of 
these residues were similar in the 
structure of PheA and the model of 
NovH, but different in CloH. 
We carried out a site-directed 
mutagenesis of CloH, mutating the 
genuine L383 to M as found in NovH. 
The resulting mutant protein clearly 
Chapter 7 Boll et al. • Role of MbtH-like Proteins in the Adenylation of Tyrosine
 
Page 97 
© 2011 The Authors. 
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. 
Originally published in The Journal of Biological Chemistry. (2011), 286, Publication ahead of print
 
showed some adenylating activity in the 
absence of CloY (0.22 nKat mg-1), 
amounting to 33 % of the activity of 
NovH. In the presence of CloY, the 
mutant protein showed an activity of 2.45 
nKat mg-1 i.e. 36 % of the value 
determined for the genuine CloH in the 
presence of CloY. Therefore the L383M 
mutation was successful in generating 
an MbtH-independent activity, but it also 
reduced the optimal activity of the 
enzyme in the presence of CloY. 
 
Discussion 
The present study shows that the 
L-tyrosine-adenylating enzymes CloH 
and SimH of aminocoumarin antibiotic 
biosynthesis, and Pcza361.18 of 
vancomycin biosynthesis, require the 
presence of MbtH-like proteins for their 
catalytic activity. In the absence of MbtH-
like proteins, their activity is lowered by 
99.0-99.8 %. This is in accordance with 
our previous observations that 
inactivation of all mbtH-like genes in a 
clorobiocin producer strain lowered 
production of this aminocoumarin 
antibiotic by 99.3 % (2). 
In contrast, the L-tyrosine-
activating enzyme NovH of novobiocin 
biosynthesis showed significant activity 
also in the absence of any MbtH-like 
protein. Again, this is in accordance with 
the in vivo data which showed that even 
after inactivation of all mbtH-like genes, 
novobiocin was still produced, in 
approximately half of the amount formed 
in an mbtH+ strain (2). 
For optimal activity of the 
adenylating enzyme, the respective 
MbtH-like protein was required in a 
molar ratio of 1:1. The two proteins 
formed complexes with each other which 
coeluted during chromatographic 
purification. Analytical gel 
chromatography indicated that the 
complex contained two monomers of the 
adenylating enzyme. We therefore 
suggest that the adenylating enzymes 
form heterotetrameric complexes with 
the MbtH-like proteins, i.e. of the type 
(SimH)2(SimY)2. 
We found that the tyrosine-
adenylating enzymes SimH and CloH 
required the MbtH-like proteins SimY 
and CloY in a molar ratio of 1:1. In 
contrast, Felnagle et al. (6) found that 
the β-lysine adenylating enzymes CmnO 
and VioO require the MbtH-like proteins 
CmnN and VioN in 16- to 32-fold molar 
excess for optimal activity in vitro. In 
contrast to the enzymes investigated in 
our study, CmnO and VioO are in vivo 
part of large NRPS assembly lines, 
composed of several proteins. The 
absence of the other proteins of the 
NRPS may possibly affect their 
conformation, activity and stability in 
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vitro, influencing also their interaction 
with MbtH-like proteins. In contrast, 
NovH, CloH, SimH and Pcza361.18 
most likely do not interact directly with 
NRPS assembly lines, but release their 
products into solution after enzymatic 
modification (Fig. 2A). We could obtain 
these tyrosine-adenylating enzymes with 
good activity by separate expression and 
subsequent mixing with the MbtH-like 
proteins in vitro. In contrast, Felnagle et 
al. (6) reported that separate expression 
of CmnO and VioO and subsequent 
mixing with the MbtH-like proteins CmnN 
and VioN gave low activity. 
Coexpression of CmnO with CmnN (or 
VioO with VioN) gave much higher 
activities, indicating some misfolding of 
the proteins during separate expression. 
The strong requirement of 
adenylating enzymes for MbtH-like 
proteins raises the question whether 
amino acid residues of MbtH-like 
proteins are involved in catalysis in the 
active center of the adenylating enzyme. 
We modeled the structure of CloH and 
NovH after the experimentally 
determined structure of PheA, a 
phenylalanine adenylating domain from 
the biosynthetic gene cluster of 
gramicidin S (23). This gene cluster does 
not contain an mbtH-like gene, and 
purified PheA shows high activity without 
addition of an MbtH-like protein (24). The 
genome sequence of the gramicidin S 
producer strain is not available, but the 
closely related strain Brevibacillus brevis 
NBRC 100599 has been sequenced. It 
shows an NRPS gene cluster closely 
related to the gramicidin cluster, but no 
mbtH-like gene in the entire genome. 
PheA is therefore expected to be an 
MbtH-independent enzyme. Modeling of 
NovH and CloH showed that all amino 
acids expected to be in contact with the 
substrates ATP and L-tyrosine and with 
the cofactor Mg2+, were identical in both 
proteins. It appears therefore unlikely 
that amino acid residues of CloY form 
direct contacts with the substrates in the 
active center of the CloH/CloY complex. 
Rather, binding of CloY may induce a 
conformational change in the structure of 
CloH which enhances activity. Some 
support for this hypothesis can be 
derived from our mutational experiment: 
exchange of Leu383 in CloH for Met (as 
found in NovH) clearly led to an activity 
of the enzyme in absence of MbtH-like 
proteins, suggesting that this amino acid 
exchange is one of the structural 
differences which are responsible for the 
MbtH-independent activity of NovH.  
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Figure 6: Activity of L-tyrosine adenylating enzymes in the presence of different MbtH-like proteins. 
Activity was determined using the PPi exchange assays. 
 
M383 does not have direct contacts to 
the substrates but appears to influence 
the conformation of other residues in the 
active center. Conformational changes in 
adenylate-forming enzymes have been 
described previously, especially 
concerning a rotation of the PCP domain 
during thioester formation. The catalytic 
site is formed by the interface between 
the A and PCP domains, which are 
connected by a flexible hinge. It includes 
a highly conserved and functionally 
important loop similar to the P-loop (25) 
found in ATPases and GTPases. This 
loop wraps around the triphosphate of 
ATP. During the adenylate formation 
changes in the active center as well as a 
displacement of the P-loop of ~ 3.5 Å 
can be observed (26). The thioester 
formation includes a major structural 
change where the PCP domain rotates 
by ~ 140° burying the ATP-binding site 
(27). MbtH-like proteins presumably 
affect only the adenylate-forming part of 
the reaction, and the available data do 
not indicate their involvement in the 
rotation of the PCP domain.The present 
study, in accordance with previous in 
vivo (2,3) and in vitro studies (6-8), 
shows that adenylating enzymes have a 
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remarkable promiscuity for MbtH-like 
proteins from various pathways and 
organisms (Fig. 6). E.g., the tyrosine-
activating enzymes investigated in our 
study were efficiently activated by CdaX, 
the MbtH protein encoded in the 
biosynthetic gene cluster of the calcium-
dependent antibiotic (CDA) from 
Streptomyces coelicolor A(3)2 (3). The 
peptide antibiotic CDA does not contain 
a tyrosyl residue or a residue derived 
from tyrosine (28). Therefore, the 
genuine function of CdaX is most likely 
related to the adenylation of another 
amino acid than tyrosine. For 
experiments in combinatorial 
biosynthesis involving genes for 
aminoacyl-adenylate forming enzymes, 
inclusion of an mbtH-like gene may be 
crucial, but there is flexibility regarding 
which mbtH-like gene is chosen. 
The biosynthetic gene cluster of 
novobiocin does not contain an mbtH-
like gene, and correspondingly NovH 
showed activity in the absence of an 
MbtH-like protein. Unexpectedly, 
however, the activity of NovH was still 
markedly stimulated by MbtH-like 
proteins such as CloY (Fig. 6). This 
finding prompted us to initiate a genome 
sequencing of the producer strain 
Streptomyces spheroides NCIMB 11891 
(syn. S. niveus) and to search for other 
mbtH orthologs which may assist in 
novobiocin biosynthesis in this strain. 
Completion of the sequence is still in 
progress, but available data confirm that 
the novobiocin gene cluster and its 
immediate vicinity do not contain an 
mbtH-like gene. However, the genome 
contains at least two mbtH orthologs 
situated distantly from the novobiocin 
cluster. The stimulation of NovH by 
MbtH-like proteins shows that, even 
when a given gene cluster does not 
contain an mbtH-like gene, a stimulation 
of the biosynthesis by mbtH-like genes 
cannot be excluded. This may need to 
be considered in the design of 
combinatorial biosynthesis experiments. 
More than 400 mbtH-like genes are 
currently found in the database. Drake et 
al. (5) solved the crystal structure of an 
MbtH-like protein from Pseudomonas 
aeruginosa. The protein displays a new 
protein fold and is shaped like a thin 
arrow head, with the point of the arrow 
formed by the C-terminal α-helix. 
Sequence comparison of 155 MbtH-like 
proteins showed that the conserved 
residues, including the three highly 
conserved tryptophans, all lie on one 
face of the protein, and the authors 
suggested that this face may interact 
with conserved components of NRPSs. 
Buchko et al. (4) determined by NMR the 
solution structure of another MbtH-like 
protein from Mycobacterium 
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tuberculosis. The solution structure was 
similar to the aforementioned crystal 
structure except for the C-terminus 
which was highly disordered in solution, 
despite high sequence conservation of 
this region in the family of MbtH-like 
proteins. The authors pointed out that 
conserved but disordered regions of 
proteins are associated with binding to 
multiple partners, and suggested that 
binding via the disordered C-terminal 
region may explain the promiscuity of 
MbtH-like proteins for interaction with 
biosynthetic enzymes from different 
pathways. 
We modeled the structure of our 
MbtH-like proteins after the published 
structures and tried to dock them to the 
tyrosine-adenylating enzymes using the 
Hex Protein Docking Server 
(http://hexserver.loria.fr). However, this 
resulted in several possible solutions. 
Therefore, the structure of these 
complexes remains speculative until a 
crystal structure can be determined. 
Many biochemical studies have 
been published on amino acid-
adenylating enzymes in secondary 
metabolism, especially in non-ribosomal 
peptide synthesis (29-31). In nearly all 
cases these enzymes have been 
expressed in E. coli strains containing an 
intact ybdZ gene. Our data suggest that 
YbdZ can copurify with, adenylating 
enzymes and that this complex formation 
can considerably affect the biochemical 
properties of the purified enzymes. We 
therefore suggest to use only ∆ybdZ 
expression strains for investigations of 
amino acid-adenylating enzymes in 
future, and to carefully re-evaluate 
previous data for possible interference 
by YbdZ. 
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Supplemental Data 
 
 
Fig. S1. Alignment of the amino acid sequences of the adenylate-forming enzymes 
NovH and CloH. The site of the mutation of CloH L383M is marked with an asterisk. 
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Fig. S2. SDS-PAGE of the purified tyrosine-adenylating enzymes CloH, SimH, NovH 
and Pcza361.18, and of the MbtH-like proteins CloY, SimY, CdaX and Orf1van. The 
calculated masses of the his-tagged tyrosine-adenylating enzymes are 65.7 for 
NovH, 65.2 for CloH, 63.2 for Pcza361.18 and 107.3 kDa for SimH. The calculated 
masses for the MbtH-like proteins are 8.3 kDa for CloY, 9.4 kDa for N-His6-SimY, 8.2 
kDa for CdaX, 8.1 for Orf1van,. The polyacrylamide gel was stained with Coomassie 
Brilliant Blue R-250. 
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Fig. S3. Michaelis-Menten kinetics of the activation of L-tyrosine by CloH, SimH, 
NovH and Pcza361.18 in the absence and presence of MbtH-like proteins. 
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Fig. S4. SDS-PAGE of the CloH/CloY complex after analytical gel filtration. 
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Abbrevations 
°C    degree Celsius 
μ    micro 
Å   Ångström (10-10 m) 
aa    amino acids 
aac(3)IV   apramycin resistance gene 
Amp    ampicillin 
ATP    adenosine triphosphate 
bp    base pair 
Cm    chloramphenicol 
CoA    coenzyme A 
Da    Dalton 
DMSO    dimethyl sulfoxide 
DNA    deoxyribonucleic acid 
dNTP    deoxyribonucleoside 5´-triphosphate 
DTT    1,4-dithiothreitol 
E. coli    Escherichia coli 
EDTA    ethylendiamine tetra-acetic acid 
h    hour 
HCl    hydrochloric acid 
HCOOH   formic acid 
His8    octahistidine 
HPLC    high performance liquid chromatography 
IPTG    isopropyl-β-thiogalactoside 
k    kilo 
KAc    potassium acetate 
Kan   kanamycin 
kb    kilo base pairs 
kcat    turnover rate 
Km    Michaelis-Menten constant 
L    liter 
lacZ    gene portion for α-complementation of β-galactosidase 
LC    liquid chromatography 
M    molar 
m    milli 
min    minute 
MS    mass spectrometry 
MW    molecular weight 
m/z    mass-to-charge ratio 
n    nano 
NADP    nicotine amide adenine dinucleotide phosphate 
NaOH    sodium hydroxide 
OD600    optical density at 600 nm 
Abbrevations
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ORF    open reading frame 
p    pico 
PAGE    polyacrylamide gel electrophoresis 
PCR    polymerase chain reaction 
PMSF    phenylmethylsulfonyl fluoride 
RNA    ribonucleic acid 
RNase    ribonuclease 
RP    reverse phase 
rpm    rounds per minute 
s    second 
S.    Streptomyces 
SDS    sodium dodecyl sulfate 
Tris    2-amino-2-(hydroxymethyl)-1,3-propanediol 
U    unit 
Vmax    maximal reaction velocity 
×g    ground acceleration 
X-gal    5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
 
